Xavier Mariette - Publications

Affiliations: 
University Paris 11 
Area:
Lymphoma, Autoimmune diseases, Sjogren's syndrome, Disease activity, IRF5, Type I interferon, Epigenetic, CD4+ T cells, Plasmacytoid dendritic cells

389 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Shankar-Hari M, Vale CL, Godolphin PJ, Fisher D, Higgins JPT, Spiga F, Savovic J, Tierney J, Baron G, Benbenishty JS, Berry LR, Broman N, Cavalcanti AB, Colman R, ... ... Mariette X, et al. Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis. Jama. PMID 34228774 DOI: 10.1001/jama.2021.11330  0.4
2021 Horellou P, de Chalus A, Giorgi L, Leroy C, Chrétien P, Hacein-Bey-Abina S, Bourgeois C, Mariette X, Serguera C, Le Grand R, Deiva K. Regulatory T Cells Increase After rh-MOG Stimulation in Non-Relapsing but Decrease in Relapsing MOG Antibody-Associated Disease at Onset in Children. Frontiers in Immunology. 12: 679770. PMID 34220827 DOI: 10.3389/fimmu.2021.679770  0.44
2021 Seror R, Nocturne G, Mariette X. Current and future therapies for primary Sjögren syndrome. Nature Reviews. Rheumatology. PMID 34188206 DOI: 10.1038/s41584-021-00634-x  1
2021 Collins A, Lendrem D, Wason J, Tarn J, Howard-Tripp N, Bodewes I, Versnel MA, Gottenberg JE, Seror R, Mariette X, Ng WF. Revisiting the JOQUER trial: stratification of primary Sjögren's syndrome and the clinical and interferon response to hydroxychloroquine. Rheumatology International. PMID 34165604 DOI: 10.1007/s00296-021-04927-y  0.76
2021 Carvès S, Ghittori MB, Henry J, Belkhir R, Besson FL, Levante S, Mariette X, Seror R. Denosumab in active Charcot neuro-osteorthropathy of the foot. Joint Bone Spine. 105241. PMID 34146697 DOI: 10.1016/j.jbspin.2021.105241  0.76
2021 Mariette X, Hermine O, Tharaux PL, Resche-Rigon M, Steg PG, Porcher R, Ravaud P. Effectiveness of Tocilizumab in Patients Hospitalized With COVID-19: A Follow-up of the CORIMUNO-TOCI-1 Randomized Clinical Trial. Jama Internal Medicine. PMID 34028504 DOI: 10.1001/jamainternmed.2021.2209  0.4
2021 Rempenault C, Lukas C, Combe B, Herrero A, Pane I, Schaeverbeke T, Wendling D, Pham T, Gottenberg JE, Mariette X, Morel J. Risk of Diverticulitis and Gastrointestinal Perforation in Rheumatoid Arthritis Treated with Tocilizumab Compared to Rituximab or Abatacept. Rheumatology (Oxford, England). PMID 33993216 DOI: 10.1093/rheumatology/keab438  0.64
2021 Combe B, Rincheval N, Berenbaum F, Boumier P, Cantagrel A, Dieude P, Dougados M, Fautrel B, Flipo RM, Goupille P, Mariette X, Saraux A, Schaeverbeke T, Sibilia J, Vittecoq O, et al. Current favourable 10-year outcome of patients with early rheumatoid arthritis: data from the ESPOIR cohort. Rheumatology (Oxford, England). PMID 33961011 DOI: 10.1093/rheumatology/keab398  0.6
2021 Bondet V, Rodero MP, Posseme C, Bost P, Decalf J, Haljasmägi L, Bekaddour N, Rice GI, Upasani V, Herbeuval JP, Reynolds JA, Briggs TA, Bruce IN, Mauri C, Isenberg D, ... ... Mariette X, et al. Differential levels of IFNα subtypes in autoimmunity and viral infection. Cytokine. 155533. PMID 33941444 DOI: 10.1016/j.cyto.2021.155533  0.6
2021 Nocturne G, Ly B, Paoletti A, Pascaud J, Seror R, Nicco C, Mackay F, Vincent FB, Lazure T, Ferlicot S, Stimmer L, Pascal Q, Roulland S, Krzysiek R, Hacein-Bey S, ... ... Mariette X, et al. Long-term exposure to monoclonal anti-TNF is associated with an increased risk of lymphoma in BAFF-transgenic mice. Clinical and Experimental Immunology. PMID 33864242 DOI: 10.1111/cei.13602  1
2021 Hermine O, Mariette X, Ravaud P. Tocilizumab in Treatment for Patients With COVID-19-Reply. Jama Internal Medicine. PMID 33818610 DOI: 10.1001/jamainternmed.2021.0407  0.4
2021 Kedra J, Nocturne G, Mariette X, Seror R. Inflammation-targeted therapies and cancer. Joint Bone Spine. 88: 105176. PMID 33771759 DOI: 10.1016/j.jbspin.2021.105176  1
2021 Cordel N, Derambure C, Coutant S, Mariette X, Jullien D, Debarbieux S, Chosidow O, Meyer A, Bessis D, Joly P, Mathian A, Levesque H, Sabourin JC, Tournier I, Boyer O, et al. TRIM33 gene somatic mutations identified by next generation sequencing in neoplasms of patients with anti-TIF1γ positive cancer-associated dermatomyositis. Rheumatology (Oxford, England). PMID 33764396 DOI: 10.1093/rheumatology/keab260  0.44
2021 Dupré A, Pascaud J, Rivière E, Paoletti A, Ly B, Mingueneau M, Mariette X, Nocturne G. Association between T follicular helper cells and T peripheral helper cells with B-cell biomarkers and disease activity in primary Sjögren syndrome. Rmd Open. 7. PMID 33688082 DOI: 10.1136/rmdopen-2020-001442  1
2021 Retamozo S, Baldini C, Bootsma H, De Vita S, Dörner T, Fisher BA, Gottenberg JE, Hernández-Molina G, Kocher A, Kostov B, Kruize AA, Mandl T, Ng WF, Seror R, Shoenfeld Y, ... ... Mariette X, et al. Therapeutic Recommendations for the Management of Older Adult Patients with Sjögren's Syndrome. Drugs & Aging. PMID 33619703 DOI: 10.1007/s40266-021-00838-6  0.76
2021 Villon C, Orgeolet L, Roguedas AM, Misery L, Gottenberg JE, Cornec D, Jousse-Joulin S, Seror R, Berthelot JM, Dieude P, Dubost JJ, Fauchais AL, Goeb V, Hachulla E, Hatron PY, ... ... Mariette X, et al. Epidemiology of cutaneous involvement in Sjögren syndrome: Data from three French pSS populations (TEARS, ASSESS, diapSS). Joint Bone Spine. 105162. PMID 33617999 DOI: 10.1016/j.jbspin.2021.105162  0.76
2021 Aringer M, Brinks R, Dörner T, Daikh D, Mosca M, Ramsey-Goldman R, Smolen JS, Wofsy D, Boumpas DT, Kamen DL, Jayne D, Cervera R, Costedoat-Chalumeau N, Diamond B, Gladman DD, ... ... Mariette X, et al. European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) SLE classification criteria item performance. Annals of the Rheumatic Diseases. PMID 33568386 DOI: 10.1136/annrheumdis-2020-219373  0.76
2021 Salliot C, Nguyen Y, Gusto G, Gelot A, Gambaretti J, Mariette X, Boutron-Ruault MC, Seror R. Female hormonal exposures and risk of rheumatoid arthritis in the French E3N-EPIC cohort study. Rheumatology (Oxford, England). PMID 33547777 DOI: 10.1093/rheumatology/keab101  0.76
2021 Alunno A, Najm A, Machado PM, Bertheussen H, Burmester GR, Carubbi F, De Marco G, Giacomelli R, Hermine O, Isaacs JD, Koné-Paut I, Magro-Checa C, McInnes I, Meroni PL, Quartuccio L, ... ... Mariette X, et al. EULAR points to consider on pathophysiology and use of immunomodulatory therapies in COVID-19. Annals of the Rheumatic Diseases. PMID 33547062 DOI: 10.1136/annrheumdis-2020-219724  0.32
2021 Al Tabaa O, Gouze H, Hamroun S, Bergé E, Belkhir R, Pavy S, Jousse-Joulin S, Mariette X. Normal salivary gland ultrasonography could rule out the diagnosis of Sjögren's syndrome in anti-SSA-negative patients with sicca syndrome. Rmd Open. 7. PMID 33510043 DOI: 10.1136/rmdopen-2020-001503  0.64
2021 Bonnet I, Rousseau A, Duraffour P, Pouchot J, Nguyen CD, Gabison E, Seror R, Marotte H, Mariette X, Nocturne G. Efficacy and safety of rituximab in peripheral ulcerative keratitis associated with rheumatoid arthritis. Rmd Open. 7. PMID 33510042 DOI: 10.1136/rmdopen-2020-001472  1
2021 Martin de Fremont G, Chiron A, Krzysiek R, Hacein-Bey-Abina S, Mariette X, Nocturne G. Flare of a mixed cryoglobulinaemic vasculitis after obinutuzumab infusion. Clinical and Experimental Rheumatology. PMID 33506759  1
2021 Barlet J, Virone A, Gomez L, Adam C, Mariette X, Durand E, Besson FL. F-FDG PET/CT and MRI findings of Shulman syndrome also known as eosinophilic fasciitis. European Journal of Nuclear Medicine and Molecular Imaging. PMID 33462629 DOI: 10.1007/s00259-020-05172-4  0.52
2021 Talarico R, Aguilera S, Alexander T, Amoura Z, Antunes AM, Arnaud L, Avcin T, Beretta L, Bombardieri S, Burmester GR, Cannizzo S, Cavagna L, Chaigne B, Cornet A, Costedoat-Chalumeau N, ... ... Mariette X, et al. The impact of COVID-19 on rare and complex connective tissue diseases: the experience of ERN ReCONNET. Nature Reviews. Rheumatology. PMID 33408338 DOI: 10.1038/s41584-020-00565-z  0.44
2020 Brito-Zerón P, Melchor S, Seror R, Priori R, Solans R, Kostov B, Baldini C, Carubbi F, Callejas JL, Guisado-Vasco P, Hernández-Molina G, Pasoto SG, Valim V, Sisó-Almirall A, Mariette X, et al. SARS-CoV-2 infection in patients with primary Sjögren syndrome: characterization and outcomes of 51 patients. Rheumatology (Oxford, England). PMID 33316070 DOI: 10.1093/rheumatology/keaa748  0.76
2020 Felten R, Devauchelle-Pensec V, Seror R, Duffau P, Saadoun D, Hachulla E, Pierre Yves H, Salliot C, Perdriger A, Morel J, Mékinian A, Vittecoq O, Berthelot JM, Dernis E, Le Guern V, ... ... Mariette X, et al. Interleukin 6 receptor inhibition in primary Sjögren syndrome: a multicentre double-blind randomised placebo-controlled trial. Annals of the Rheumatic Diseases. PMID 33208345 DOI: 10.1136/annrheumdis-2020-218467  0.76
2020 Hässler S, Bachelet D, Duhaze J, Szely N, Gleizes A, Hacein-Bey Abina S, Aktas O, Auer M, Avouac J, Birchler M, Bouhnik Y, Brocq O, Buck-Martin D, Cadiot G, Carbonnel F, ... ... Mariette X, et al. Clinicogenomic factors of biotherapy immunogenicity in autoimmune disease: A prospective multicohort study of the ABIRISK consortium. Plos Medicine. 17: e1003348. PMID 33125391 DOI: 10.1371/journal.pmed.1003348  0.44
2020 Hermine O, Mariette X, Tharaux PL, Resche-Rigon M, Porcher R, Ravaud P. Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia: A Randomized Clinical Trial. Jama Internal Medicine. PMID 33080017 DOI: 10.1001/jamainternmed.2020.6820  0.4
2020 Molto A, Gossec L, Poiraudeau S, Claudepierre P, Soubrier M, Fayet F, Wendling D, Gaudin P, Dernis E, Guis S, Pouplin S, Ruyssen-Witrand A, Chales G, Mariette X, Beauvais C, et al. Evaluation of the impact of a nurse-led program of patient self-assessment and self-management in axial spondyloarthritis: results of a prospective, multicentre, randomized, controlled trial (COMEDSPA). Rheumatology (Oxford, England). PMID 33063096 DOI: 10.1093/rheumatology/keaa480  0.6
2020 Rivière E, Mariette X, Nocturne G. Response to: 'Role of interaction between B cells and epithelial cells in pSS' by Pringle . Annals of the Rheumatic Diseases. PMID 33060074 DOI: 10.1136/annrheumdis-2020-219096  1
2020 Rivière E, Pascaud J, Virone A, Dupré A, Ly B, Paoletti A, Seror R, Tchitchek N, Mingueneau M, Smith N, Duffy D, Cassard L, Chaput N, Pengam S, Gauttier V, ... ... Mariette X, et al. Interleukin-7/Interferon axis drives T-cell and salivary gland epithelial cell interactions in Sjögren's syndrome. Arthritis & Rheumatology (Hoboken, N.J.). PMID 33058491 DOI: 10.1002/art.41558  1
2020 Brito-Zerón P, Pasoto SG, Robles-Marhuenda A, Mandl T, Vissink A, Armagan B, Praprotnik S, Nocturne G, Sebastian A, Fernandes Moça Trevisani V, Retamozo S, Acar-Denizli N, Wiland P, Sisó-Almirall A, Bootsma H, ... Mariette X, et al. Autoimmune congenital heart block and primary Sjögren's syndrome: characterisation and outcomes of 49 cases. Clinical and Experimental Rheumatology. PMID 33025893  1
2020 Blanchet B, Jallouli M, Allard M, Ghillani-Dalbin P, Galicier L, Aumaître O, Chasset F, Le Guern V, Lioté F, Smail A, Limal N, Perard L, Desmurs-Clavel H, Le Thi Huong D, Asli B, ... ... Mariette X, et al. Hydroxychloroquine levels in patients with systemic lupus erythematosus: whole blood is preferable but serum levels also detect non-adherence. Arthritis Research & Therapy. 22: 223. PMID 32977856 DOI: 10.1186/s13075-020-02291-z  0.68
2020 Juarez M, Diaz N, Johnston GI, Nayar S, Payne A, Helmer E, Cain D, Williams P, Devauchelle-Pensec V, Fisher BA, Giacomelli R, Gottenberg JE, Guggino G, Kvarnström M, Mariette X, et al. A phase 2 randomized, double-blind, placebo-controlled, proof-of-concept study of oral seletalisib in primary Sjögren's syndrome. Rheumatology (Oxford, England). PMID 32949140 DOI: 10.1093/rheumatology/keaa410  0.64
2020 Nguyen Y, Salliot C, Gelot A, Gambaretti J, Mariette X, Boutron-Ruault MC, Seror R. Mediterranean diet and risk of rheumatoid arthritis: findings from the French E3N-EPIC cohort study. Arthritis & Rheumatology (Hoboken, N.J.). PMID 32909390 DOI: 10.1002/art.41487  0.76
2020 Rivière E, Pascaud J, Tchitchek N, Boudaoud S, Paoletti A, Ly B, Dupré A, Chen H, Thai A, Allaire N, Jagla B, Mingueneau M, Nocturne G, Mariette X. Salivary gland epithelial cells from patients with Sjögren's syndrome induce B-lymphocyte survival and activation. Annals of the Rheumatic Diseases. PMID 32843324 DOI: 10.1136/Annrheumdis-2019-216588  1
2020 Johnson SR, Brinks R, Costenbader KH, Daikh D, Mosca M, Ramsey-Goldman R, Smolen JS, Wofsy D, Boumpas DT, Kamen DL, Jayne D, Cervera R, Costedoat-Chalumeau N, Diamond B, Gladman DD, ... ... Mariette X, et al. Performance of the 2019 EULAR/ACR classification criteria for systemic lupus erythematosus in early disease, across sexes and ethnicities. Annals of the Rheumatic Diseases. PMID 32816709 DOI: 10.1136/Annrheumdis-2020-217162  0.76
2020 Courvoisier DS, Chatzidionysiou K, Mongin D, Lauper K, Mariette X, Morel J, Gottenberg JE, Bergstra SA, Suarez MP, Codreanu C, Kvien TK, Santos MJ, Pavelka K, Hetland ML, Askling J, et al. The impact of seropositivity on the effectiveness of biologic anti-rheumatic agents: results from a collaboration of 16 registries. Rheumatology (Oxford, England). PMID 32810263 DOI: 10.1093/Rheumatology/Keaa393  0.64
2020 Felten R, Giannini M, Nespola B, Lannes B, Levy D, Seror R, Vittecoq O, Hachulla E, Perdriger A, Dieude P, Dubost JJ, Fauchais AL, Le Guern V, Larroche C, Dernis E, ... ... Mariette X, et al. Refining myositis associated with primary Sjögren's syndrome: data from the prospective cohort ASSESS. Rheumatology (Oxford, England). PMID 32780813 DOI: 10.1093/rheumatology/keaa257  0.76
2020 Molto A, Gossec L, Poiraudeau S, Claudepierre P, Soubrier M, Fayet F, Wendling D, Gaudin P, Dernis E, Guis S, Pouplin S, Ruyssen A, Chales G, Mariette X, Beauvais C, et al. Evaluation of the impact of a nurse-led program of systematic screening of comorbidities in patients with axial spondyloarthritis: The results of the COMEDSPA prospective, controlled, one year randomized trial. Seminars in Arthritis and Rheumatism. 50: 701-708. PMID 32521324 DOI: 10.1016/J.Semarthrit.2020.05.012  0.6
2020 Nguyen Y, Mariette X, Salliot C, Gusto G, Boutron-Ruault MC, Seror R. Chronic diarrhoea and risk of rheumatoid arthritis: findings from the French E3N-EPIC Cohort Study. Rheumatology (Oxford, England). PMID 32417889 DOI: 10.1093/rheumatology/keaa133  0.76
2020 Chevalier K, Belkhir R, Seror R, Mariette X, Nocturne G. Efficacity of a sequential treatment by anti-CD 20 monoclonal antibody and belimumab in type II cryoglobulinaemia associated with primary Sjögren syndrome refractory to rituximab alone. Annals of the Rheumatic Diseases. PMID 32398282 DOI: 10.1136/Annrheumdis-2020-217481  1
2020 Ramos-Casals M, Brahmer JR, Callahan MK, Flores-Chávez A, Keegan N, Khamashta MA, Lambotte O, Mariette X, Prat A, Suárez-Almazor ME. Immune-related adverse events of checkpoint inhibitors. Nature Reviews. Disease Primers. 6: 38. PMID 32382051 DOI: 10.1038/s41572-020-0160-6  0.52
2020 Beydon M, Chevalier K, Al Tabaa O, Hamroun S, Delettre AS, Thomas M, Herrou J, Riviere E, Mariette X. Myositis as a manifestation of SARS-CoV-2. Annals of the Rheumatic Diseases. PMID 32327427 DOI: 10.1136/annrheumdis-2020-217573  0.52
2020 Kostine M, Finckh A, Bingham CO, Visser K, Leipe J, Schulze-Koops H, Choy EH, Benesova K, Radstake TRDJ, Cope AP, Lambotte O, Gottenberg JE, Allenbach Y, Visser M, Rusthoven C, ... ... Mariette X, et al. EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitors. Annals of the Rheumatic Diseases. PMID 32327425 DOI: 10.1136/annrheumdis-2020-217139  0.64
2020 Duhazé J, Hässler S, Bachelet D, Gleizes A, Hacein-Bey-Abina S, Allez M, Deisenhammer F, Fogdell-Hahn A, Mariette X, Pallardy M, Broët P. A Machine Learning Approach for High-Dimensional Time-to-Event Prediction With Application to Immunogenicity of Biotherapies in the ABIRISK Cohort. Frontiers in Immunology. 11: 608. PMID 32318076 DOI: 10.3389/fimmu.2020.00608  0.32
2020 Dupré A, Collins M, Nocturne G, Carbonnel F, Mariette X, Seror R. Articular manifestations in patients with inflammatory bowel disease treated with vedolizumab. Rheumatology (Oxford, England). PMID 32259251 DOI: 10.1093/rheumatology/keaa107  1
2020 Duhazé J, Caubet M, Hässler S, Bachelet D, Allez M, Deisenhammer F, Fogdell-Hahn A, Gleizes A, Hacein-Bey-Abina S, Mariette X, Pallardy M, Broët P. Assessing the effect of genetic markers on drug immunogenicity from a mechanistic model-based approach. Bmc Medical Research Methodology. 20: 69. PMID 32192445 DOI: 10.1186/S12874-020-00941-Z  0.32
2020 Martin de Fremont G, Belkhir R, Henry J, Voisin AL, Lambotte O, Besson FL, Mariette X, Nocturne G. Features of polymyalgia rheumatica-like syndrome after immune checkpoint inhibitor therapy. Annals of the Rheumatic Diseases. PMID 32188691 DOI: 10.1136/annrheumdis-2020-217225  1
2020 Michot JM, Lappara A, Le Pavec J, Simonaggio A, Collins M, De Martin E, Danlos FX, Ammari S, Cauquil C, Ederhy S, Barreau E, Belkhir R, Berdelou A, Lazarovici J, Chanson P, ... ... Mariette X, et al. The 2016-2019 ImmunoTOX assessment board report of collaborative management of immune-related adverse events, an observational clinical study. European Journal of Cancer (Oxford, England : 1990). 130: 39-50. PMID 32172197 DOI: 10.1016/J.Ejca.2020.02.010  0.52
2020 Duret PM, Meyer N, Saraux A, Devauchelle-Pensec V, Seror R, Le-Guern V, Larroche C, Perdriger A, Sibilia J, Guardiolle V, Mariette X, Gottenberg JE. Seasonal effect on fatigue, pain and dryness in primary Sjögren's syndrome. Arthritis Research & Therapy. 22: 39. PMID 32093783 DOI: 10.1186/S13075-020-2118-1  0.76
2020 Descamps E, Henry J, Labeyrie C, Adams D, Nasser GA, Vandendries C, Adam C, Aiello D, Mariette X, Seror R. Small fiber neuropathy in Sjögren's syndrome: comparison with other small fiber neuropathies. Muscle & Nerve. PMID 32012291 DOI: 10.1002/mus.26824  0.76
2020 Smolen JS, Landewé RBM, Bijlsma JWJ, Burmester GR, Dougados M, Kerschbaumer A, McInnes IB, Sepriano A, van Vollenhoven RF, de Wit M, Aletaha D, Aringer M, Askling J, Balsa A, Boers M, ... ... Mariette X, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Annals of the Rheumatic Diseases. PMID 31969328 DOI: 10.1136/annrheumdis-2019-216655  0.64
2020 Aringer M, Brinks R, Costenbader K, Boumpas D, Daikh D, Jayne D, Kamen DL, Mosca M, Ramsey-Goldman R, Smolen JS, Wofsy D, Diamond B, Jacobsen S, McCune WJ, Ruiz-Irastorza G, ... ... Mariette X, et al. O8 Performance of the EULAR/ACR 2019 classification criteria for systemic lupus erythematosus in men, ethnicities, and early disease Lupus Science & Medicine. 7. DOI: 10.1136/Lupus-2020-Eurolupus.21  0.76
2020 Cachen L, Nocturne G, Collins M, Meyer A, Carbonnel F, Mariette X, Seror R. Thu0382 Articular Manifestations In Patients With Inflammatory Bowel Diseases Treated With Anti-Tnfα Annals of the Rheumatic Diseases. 79: 425-425. DOI: 10.1136/Annrheumdis-2020-Eular.2563  1
2020 Johnson S, Brinks R, Costenbader K, Daikh D, Mosca M, Ramsey-Goldman R, Smolen JS, Wofsy D, Boumpas D, Kamen DL, Jayne D, Cervera R, Costedoat-Chalumeau N, Diamond B, Gladman DD, ... ... Mariette X, et al. Thu0271 Performance Of The Eular/Acr 2019 Classification Criteria For Systemic Lupus Erythematosus In Early Disease, Across Sexes And Ethnicities Annals of the Rheumatic Diseases. 79: 362-362. DOI: 10.1136/Annrheumdis-2020-Eular.2324  0.76
2019 Brito-Zerón P, Acar-Denizli N, Ng WF, Horváth IF, Rasmussen A, Seror R, Li X, Baldini C, Gottenberg JE, Danda D, Quartuccio L, Priori R, Hernandez-Molina G, Armagan B, Kruize AA, ... ... Mariette X, et al. Epidemiological profile and north-south gradient driving baseline systemic involvement of primary Sjögren's syndrome. Rheumatology (Oxford, England). PMID 31873754 DOI: 10.1093/Rheumatology/Kez578  0.76
2019 Nguyen Y, Salliot C, Gusto G, Descamps E, Mariette X, Boutron-Ruault MC, Seror R. Improving accuracy of self-reported diagnoses of rheumatoid arthritis in the French prospective E3N-EPIC cohort: a validation study. Bmj Open. 9: e033536. PMID 31848174 DOI: 10.1136/bmjopen-2019-033536  0.76
2019 Brito-Zerón P, Retamozo S, Kostov B, Baldini C, Bootsma H, De Vita S, Dörner T, Gottenberg JE, Kruize AA, Mandl T, Ng WF, Seror R, Tzioufas AG, Vitali C, Bowman S, ... Mariette X, et al. Efficacy and safety of topical and systemic medications: a systematic literature review informing the EULAR recommendations for the management of Sjögren's syndrome. Rmd Open. 5: e001064. PMID 31749986 DOI: 10.1136/Rmdopen-2019-001064  0.76
2019 Leite Pereira A, Bitoun S, Paoletti A, Nocturne G, Marcos Lopez E, Cosma A, Le Grand R, Mariette X, Tchitchek N. Characterization of Phenotypes and Functional Activities of Leukocytes From Rheumatoid Arthritis Patients by Mass Cytometry. Frontiers in Immunology. 10: 2384. PMID 31681279 DOI: 10.3389/Fimmu.2019.02384  1
2019 Baber A, Nocturne G, Krzysiek R, Henry J, Belkhir R, Mariette X, Seror R. Large granular lymphocyte expansions in primary Sjögren's syndrome: characteristics and outcomes. Rmd Open. 5: e001044. PMID 31673421 DOI: 10.1136/Rmdopen-2019-001044  1
2019 Abbara S, Seror R, Henry J, Chretien P, Gleizes A, Hacein-Bey-Abina S, Mariette X, Nocturne G. Anti-RNP positivity in primary Sjögren's syndrome is associated with a more active disease and a more frequent muscular and pulmonary involvement. Rmd Open. 5: e001033. PMID 31673417 DOI: 10.1136/Rmdopen-2019-001033  1
2019 Ramos-Casals M, Brito-Zerón P, Bombardieri S, Bootsma H, De Vita S, Dörner T, Fisher BA, Gottenberg JE, Hernandez-Molina G, Kocher A, Kostov B, Kruize AA, Mandl T, Ng WF, Retamozo S, ... ... Mariette X, et al. EULAR recommendations for the management of Sjögren's syndrome with topical and systemic therapies. Annals of the Rheumatic Diseases. PMID 31672775 DOI: 10.1136/Annrheumdis-2019-216114  0.76
2019 Nocturne G, Pascaud J, Ly B, Tahmasebi F, Mariette X. JAK inhibitors alter NK cell functions and may impair immunosurveillance against lymphomagenesis. Cellular & Molecular Immunology. PMID 31664224 DOI: 10.1038/s41423-019-0320-3  1
2019 Jousse-Joulin S, Gatineau F, Baldini C, Baer A, Barone F, Bootsma H, Bowman S, Brito-Zerón P, Cornec D, Dorner T, de Vita S, Fisher B, Hammenfors D, Jonsson M, Mariette X, et al. Weight of Salivary-Gland Ultrasonography compared to Other items of the 2016 ACR/EULAR Classification Criteria for Primary Sjögren's Syndrome. Journal of Internal Medicine. PMID 31618794 DOI: 10.1111/Joim.12992  0.76
2019 Combier A, Nocturne G, Henry J, Belkhir R, Pavy S, Le Tiec C, Descamps E, Seror R, Mariette X. Immunization to rituximab is more frequent in systemic autoimmune diseases than in rheumatoid arthritis: ofatumumab as alternative therapy. Rheumatology (Oxford, England). PMID 31613955 DOI: 10.1093/Rheumatology/Kez430  1
2019 Mariette X, Perrodeau E, Verner C, Struillou X, Picard N, Schaeverbeke T, Constantin A, Ravaud P, Bouchard P. Role of good oral hygiene on clinical evolution of rheumatoid arthritis: a randomized study nested in the ESPOIR cohort. Rheumatology (Oxford, England). PMID 31504982 DOI: 10.1093/Rheumatology/Kez368  0.4
2019 Assan F, Seror R, Mariette X, Nocturne G. New 2019 SLE EULAR/ACR classification criteria are valuable for distinguishing patients with SLE from patients with pSS. Annals of the Rheumatic Diseases. PMID 31501139 DOI: 10.1136/annrheumdis-2019-216222  1
2019 Paoletti A, Rohmer J, Ly B, Pascaud J, Rivière E, Seror R, Le Goff B, Nocturne G, Mariette X. Monocyte/Macrophage Abnormalities Specific to Rheumatoid Arthritis Are Linked to miR-155 and Are Differentially Modulated by Different TNF Inhibitors. Journal of Immunology (Baltimore, Md. : 1950). PMID 31484730 DOI: 10.4049/Jimmunol.1900386  1
2019 Ramos-Casals M, Maria A, Suárez-Almazor ME, Lambotte O, Fisher BA, Hernández-Molina G, Guilpain P, Pundole X, Flores-Chávez A, Baldini C, Bingham Iii CO, Brito-Zerón P, Gottenberg JE, Kostine M, Radstake TRD, ... ... Mariette X, et al. Sicca/Sjögren's syndrome triggered by PD-1/PD-L1 checkpoint inhibitors. Data from the International ImmunoCancer Registry (ICIR). Clinical and Experimental Rheumatology. 37: 114-122. PMID 31464670  0.64
2019 Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, Smolen JS, Wofsy D, Boumpas DT, Kamen DL, Jayne D, Cervera R, Costedoat-Chalumeau N, Diamond B, Gladman DD, ... ... Mariette X, et al. 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus. Arthritis & Rheumatology (Hoboken, N.J.). PMID 31385462 DOI: 10.1002/Art.40930  0.76
2019 Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, Smolen JS, Wofsy D, Boumpas DT, Kamen DL, Jayne D, Cervera R, Costedoat-Chalumeau N, Diamond B, Gladman DD, ... ... Mariette X, et al. 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Annals of the Rheumatic Diseases. PMID 31383717 DOI: 10.1136/Annrheumdis-2018-214819  0.76
2019 Gossec L, Soubrier M, Foissac F, Molto A, Richette P, Beauvais C, Ruyssen-Witrand A, Perdriger A, Chary-Valckenaere I, Mouterde G, Dernis E, Euller-Ziegler L, Flipo RM, Gilson M, Guis S, ... Mariette X, et al. Screening for and management of comorbidities after a nurse-led program: results of a 3-year longitudinal study in 769 established rheumatoid arthritis patients. Rmd Open. 5: e000914. PMID 31275607 DOI: 10.1136/Rmdopen-2019-000914  0.32
2019 Bodewes ILA, Gottenberg JE, van Helden-Meeuwsen CG, Mariette X, Versnel MA. Hydroxychloroquine treatment downregulates systemic interferon activation in primary Sjögren's syndrome in the JOQUER randomized trial. Rheumatology (Oxford, England). PMID 31237947 DOI: 10.1093/Rheumatology/Kez242  0.64
2019 Sanosyan A, Daien C, Nutz A, Bollore K, Bedin AS, Morel J, Zimmermann V, Nocturne G, Peries M, Guigue N, Gottenberg JE, Van de Perre P, Mariette X, Tuaillon E. Discrepancy of Serological and Molecular Patterns of Circulating Epstein-Barr Virus Reactivation in Primary Sjögren's Syndrome. Frontiers in Immunology. 10: 1153. PMID 31191532 DOI: 10.3389/Fimmu.2019.01153  1
2019 Bitoun S, Roques P, Maillere B, Le Grand R, Mariette X. Valine 11 and phenylalanine 13 have a greater impact on the T-cell response to citrullinated peptides than the 70-74 shared epitope of the DRB1 molecule in macaques. Annals of the Rheumatic Diseases. PMID 31023654 DOI: 10.1136/Annrheumdis-2019-215114  0.44
2019 Gossec L, Fayet F, Soubrier M, Foissac F, Molto A, Richette P, Beauvais C, Ruyssen-Witrand A, Perdriger A, Chary-Valckenaere I, Mouterde G, Dernis E, Euller-Ziegler L, Flipo RM, Gilson M, ... ... Mariette X, et al. Is self-assessment by patients of disease activity acceptable over the long term in rheumatoid arthritis? A 3-year follow-up of 771 patients. Rheumatology (Oxford, England). PMID 30915463 DOI: 10.1093/Rheumatology/Kez094  0.32
2019 Nocturne G, Pontarini E, Bombardieri M, Mariette X. Lymphomas complicating primary Sjögren's syndrome: from autoimmunity to lymphoma. Rheumatology (Oxford, England). PMID 30838413 DOI: 10.1093/Rheumatology/Kez052  1
2019 Gottenberg JE, Morel J, Perrodeau E, Bardin T, Combe B, Dougados M, Flipo RM, Saraux A, Schaeverbeke T, Sibilia J, Soubrier M, Vittecoq O, Baron G, Constantin A, Ravaud P, ... Mariette X, et al. Comparative effectiveness of rituximab, abatacept, and tocilizumab in adults with rheumatoid arthritis and inadequate response to TNF inhibitors: prospective cohort study. Bmj (Clinical Research Ed.). 364: l67. PMID 30679233 DOI: 10.1136/Bmj.L67  0.64
2019 Keraen J, Blanc E, Besson FL, Leguern V, Meyer C, Henry J, Belkhir R, Nocturne G, Mariette X, Seror R. Usefulness of F-FDG Positron Emission Tomography (PET) for the diagnosis of lymphoma in primary Sjögren's syndrome. Arthritis & Rheumatology (Hoboken, N.J.). PMID 30615273 DOI: 10.1002/Art.40829  1
2019 Ramos-Casals M, Brito-Zerón P, Bombardieri S, Bootsma H, Vita SD, Dörner T, Fisher BA, Gottenberg J, Hernández-Molina G, Kocher A, Kostov B, Kruize AA, Mandl T, Ng W, Retamozo S, ... ... Mariette X, et al. SP0190 2019 EULAR RECOMMENDATIONS FOR THE MANAGEMENT OF SJöGREN”S SYNDROME WITH TOPICAL AND SYSTEMIC THERAPIES Annals of the Rheumatic Diseases. 78: 59-59. DOI: 10.1136/Annrheumdis-2019-Eular.8570  0.76
2019 Marinello D, Ticciati S, Talarico R, Alexander T, Arnaud L, Cavagna L, Beretta L, Chaigne B, Cornet A, Costedoat-Chalumeau N, Fischer-Betz R, Frank CH, Galetti I, Grunert J, Guimaraes V, ... ... Mariette X, et al. Fri0607 Identification Of Unmet Needs Related To Rare And Complex Connective Tissue And Musculoskeletal Diseases (Rctds) Across Eu: The Experience Of The Ern Reconnet Annals of the Rheumatic Diseases. 78: 999-999. DOI: 10.1136/Annrheumdis-2019-Eular.7558  0.44
2019 Kostine M, Finckh A, Bingham C, Visser K, Leipe J, Schulze-Koops H, Choy E, Benesova K, Radstake TR, Cope A, Lambotte O, Gottenberg J, Allenbach Y, Visser M, Rusthoven C, ... ... Mariette X, et al. Op0165 Eular Recommendations For The Diagnosis And The Management Of Rheumatic Immune-Related Adverse Events Due To Cancer Immunotherapy Annals of the Rheumatic Diseases. 78: 158-158. DOI: 10.1136/Annrheumdis-2019-Eular.7372  0.52
2019 Salliot C, Nguyen Y, Gambaretti J, Gelot A, Mariette X, Boutron-Ruault M, Seror R. Thu0686 Early Menopause And/Or Duration Of Menopausal Hormonal Treatment May Increase The Risk Of Rheumatoid Arthritis In Tobacco Exposed Women: Results Of The E3N Cohort Annals of the Rheumatic Diseases. 78: 639-640. DOI: 10.1136/Annrheumdis-2019-Eular.6599  0.76
2019 Paoletti A, Reynaud F, Rohmer J, Pascaud J, Ly B, Rivière E, Tsapis N, Fattal E, Nocturne G, Mariette X. Sat0057 Increased Microrna-155 Is Associated With A Specific Defect Of Anti-Inflammatory M2 Macrophages Polarization Both In Human Rheumatoid Arthritis And In Collagen-Induced-Arthritis Mice Annals of the Rheumatic Diseases. DOI: 10.1136/Annrheumdis-2019-Eular.5415  1
2019 Joanna K, Dieudé P, Marotte H, Lafourcade A, Ducourau E, Schaeverbeke T, Perdriger A, Soubrier M, Morel J, Constantin A, Dernis E, Royant V, Salmon J, Pham T, Gottenberg J, ... ... Mariette X, et al. Fri0100 Towards The Lowest Efficacious Dose (Toledo): Results Of A Multicenter Non-Inferiority Randomized Open-Label Controlled Trial Assessing Tocilizumab Or Abatacept Injection Spacing In Rheumatoid Arthritis Patients In Remission Annals of the Rheumatic Diseases. DOI: 10.1136/Annrheumdis-2019-Eular.5060  0.52
2019 Juarez M, Diaz N, Johnston GI, Nayar S, Payne A, Helmer E, Cain D, Williams P, Ng WF, Fisher B, Gottenberg J, Guggino G, Mariette X, Kvarnström M, Devauchelle-Pensec V, et al. Ab0458 A Phase Ii Randomised, Double-Blind, Placebo-Controlled, Proof Of Concept Study Of Oral Seletalisib In Patients With Primary Sjögren’S Syndrome (Pss) Annals of the Rheumatic Diseases. 78: 1692-1693. DOI: 10.1136/Annrheumdis-2019-Eular.4887  0.52
2019 Rivière E, Pascaud J, Tchitchek N, Boudaoud S, Paoletti A, Ly B, Thai A, Allaire N, Jagla B, Mingueneau M, Nocturne G, Mariette X. Ab0190 Crosstalk Between Salivary Gland Epithelial Cells And B Lymphocytes In Primary Sjögren’S Syndrome Annals of the Rheumatic Diseases. DOI: 10.1136/Annrheumdis-2019-Eular.4121  1
2019 Dupré A, Collins M, Carbonnel F, Mariette X, Nocturne G, Seror R. Sat0324 Articular Manifestations In Patients With Inflammatory Bowel Disease Treated With Vedolizumab Annals of the Rheumatic Diseases. 78: 1240-1241. DOI: 10.1136/Annrheumdis-2019-Eular.3969  1
2019 Combier A, Nocturne G, Henry J, Belkhir R, Pavy S, Mariette X, Seror R. Ab0462 Immunizationto Rituximab Is More Frequent In Autoimmune Systemic Autoimmune Diseases Than In Rheumatoid Arthritis And May Be Managed By Switching From Rituximab To Ofatumumab Annals of the Rheumatic Diseases. DOI: 10.1136/Annrheumdis-2019-Eular.3343  1
2019 Ramos-Casals M, Lambotte O, Kostine M, Calabrese L, Suarez-Almazor M, Bingham C, Radstake TR, Baldini C, Schaeverbeke T, Gottenberg J, Schulze-Koops H, Leipe J, Calabrese C, Brito-Zerón P, Flores-Chávez A, ... ... Mariette X, et al. Thu0649 Phenotypic Clusters Of Rheumatic/Systemic Immune-Related Adverse Events Induced By Cancer Immunotherapies (Immunocancer International Registry) Annals of the Rheumatic Diseases. 78: 620-621. DOI: 10.1136/Annrheumdis-2019-Eular.2870  0.52
2019 Ramos-Casals M, Lambotte O, Kostine M, Calabrese L, Suarez-Almazor M, Bingham C, Radstake TR, Baldini C, Schaeverbeke T, Gottenberg J, Schulze-Koops H, Leipe J, Calabrese C, Brito-Zerón P, Flores-Chávez A, ... ... Mariette X, et al. Thu0628 Immune-Related Adverse Events Induced By Cancer Immunotherapies. Big Data Analysis Of 13,051 Cases (Immunocancer International Registry) Annals of the Rheumatic Diseases. 78: 607-608. DOI: 10.1136/Annrheumdis-2019-Eular.2707  0.52
2019 Retamozo S, Acar-Denizli N, Ng WF, Horváth IF, Rasmussen A, Seror R, Xiaomei L, Baldini C, Gottenberg J, Sandhya P, Quartuccio L, Priori R, Hernandez-Molina G, Armagan B, Kruize AA, ... ... Mariette X, et al. Thu0277 How The Age At Diagnosis Modifies The Phenotype Of Primary Sjögren Syndrome: Analysis In 11,420 Patients (Big Data Sjögren Project) Annals of the Rheumatic Diseases. DOI: 10.1136/Annrheumdis-2019-Eular.2428  0.76
2019 Retamozo S, Acar-Denizli N, Ng WF, Horváth IF, Rasmussen A, Seror R, Xiaomei L, Baldini C, Gottenberg J, Sandhya P, Quartuccio L, Priori R, Hernandez-Molina G, Armagan B, Kruize AA, ... ... Mariette X, et al. Ab0550 Phenotype Of Biopsy-Proven Patients With Primary Sjögren Syndrome Lacking Ro Autoantibodies: High Frequency Of Dryness Symptoms With Low Systemic Activity (Big Data Sjögren Project) Annals of the Rheumatic Diseases. DOI: 10.1136/Annrheumdis-2019-Eular.2259  0.76
2019 Szafors P, Lukas C, Gottenberg J, Mariette X, Combe B, Morel J. Sat0179 Change In Immunological Parameters During Follow-Up Of Patients With Primary Sjögren’S Syndrome: Data From The French Assess Cohort Annals of the Rheumatic Diseases. DOI: 10.1136/Annrheumdis-2019-Eular.2241  0.52
2019 Paoletti A, Rohmer J, Ly B, Pascaud J, Riviere E, Nocturne G, Mariette X. P034 Presence of a specific defect in M2 polarization of blood monocytes from patients with rheumatoid arthritis, associated with increased microRNA-155 Annals of the Rheumatic Diseases. 78. DOI: 10.1136/Annrheumdis-2018-Ewrr2019.26  1
2018 Magill L, Adriani M, Berthou V, Chen K, Gleizes A, Hacein-Bey-Abina S, Hincelin-Mery A, Mariette X, Pallardy M, Spindeldreher S, Szely N, Isenberg DA, Manson JJ, Jury EC, Mauri C. Low Percentage of Signal Regulatory Protein α/β Memory B Cells in Blood Predicts Development of Anti-drug Antibodies (ADA) in Adalimumab-Treated Rheumatoid Arthritis Patients. Frontiers in Immunology. 9: 2865. PMID 30568660 DOI: 10.3389/Fimmu.2018.02865  0.32
2018 Anquetil C, Hachulla E, Machuron F, Mariette X, Le Guern V, Vittecoq O, Dernis E, Larroche C, Dubost JJ, Perdriger A, Devauchelle-Pensec V, Fauchais AL, Morel J, Dieudé P, Rist S, et al. Is early-onset primary Sjögren's syndrome a worse prognosis form of the disease? Rheumatology (Oxford, England). PMID 30561748 DOI: 10.1093/Rheumatology/Key392  0.64
2018 Quistrebert J, Hässler S, Bachelet D, Mbogning C, Musters A, Tak PP, Wijbrandts CA, Herenius M, Bergstra SA, Akdemir G, Johannesson M, Combe B, Fautrel B, Chollet-Martin S, Gleizes A, ... ... Mariette X, et al. Incidence and risk factors for adalimumab and infliximab anti-drug antibodies in rheumatoid arthritis: A European retrospective multicohort analysis. Seminars in Arthritis and Rheumatism. PMID 30420245 DOI: 10.1016/J.Semarthrit.2018.10.006  0.32
2018 Mirouse A, Seror R, Vicaut E, Mariette X, Dougados M, Fauchais AL, Deroux A, Dellal A, Costedoat-Chalumeau N, Denis G, Sellam J, Arlet JB, Lavigne C, Urbanski G, Fischer-Dumont D, et al. Arthritis in primary Sjögren's syndrome: Characteristics, outcome and treatment from French multicenter retrospective study. Autoimmunity Reviews. PMID 30408585 DOI: 10.1016/J.Autrev.2018.06.015  0.76
2018 Romão VC, Talarico R, Scirè CA, Vieira A, Alexander T, Baldini C, Gottenberg JE, Gruner H, Hachulla E, Mouthon L, Orlandi M, Pamfil C, Pineton de Chambrun M, Taglietti M, Toplak N, ... ... Mariette X, et al. Sjögren's syndrome: state of the art on clinical practice guidelines. Rmd Open. 4: e000789. PMID 30402274 DOI: 10.1136/Rmdopen-2018-000789  0.64
2018 Park JK, Lee YJ, Bitoun S, Winthrop KL, Choi Y, Lee EB, Mariette X. Interaction between B-cell activation factor and methotrexate impacts immunogenicity of seasonal influenza vaccination in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases. PMID 30297326 DOI: 10.1136/Annrheumdis-2018-214025  0.44
2018 Brito-Zerón P, Acar-Denizli N, Ng WF, Zeher M, Rasmussen A, Mandl T, Seror R, Li X, Baldini C, Gottenberg JE, Danda D, Quartuccio L, Priori R, Hernandez-Molina G, Armagan B, ... ... Mariette X, et al. How immunological profile drives clinical phenotype of primary Sjögren's syndrome at diagnosis: analysis of 10,500 patients (Sjögren Big Data Project). Clinical and Experimental Rheumatology. 36: 102-112. PMID 30156539  0.76
2018 Seror R, Henry J, Gusto G, Aubin HJ, Boutron-Ruault MC, Mariette X. Passive smoking in childhood increases the risk of developing rheumatoid arthritis. Rheumatology (Oxford, England). PMID 30124939 DOI: 10.1093/rheumatology/key219  0.76
2018 Samson M, Devilliers H, Ly KH, Maurier F, Bienvenu B, Terrier B, Charles P, Guillevin L, Besancenot JF, Liozon E, Fauchais AL, Loffroy R, Binquet C, Audia S, Seror R, ... Mariette X, et al. Tocilizumab as an add-on therapy to glucocorticoids during the first 3 months of treatment of Giant cell arteritis: A prospective study. European Journal of Internal Medicine. PMID 30054122 DOI: 10.1016/J.Ejim.2018.06.008  0.76
2018 Nocturne G, Seror R, Mariette X. Is miR200b-5p a new predictor of lymphoma or associated with lymphocytes infiltrate within salivary glands? Annals of the Rheumatic Diseases. PMID 30030264 DOI: 10.1136/Annrheumdis-2018-213979  1
2018 Bitoun S, Miceli-Richard C, Verstuyft C, Juge PA, Dieudé P, Berthelot JM, Richez C, Cauquil C, Sordet C, Melac-Ducamp S, Gossec L, Bouvard B, Dernis E, Houvenagel E, Boutry-Bacle MA, ... Mariette X, et al. Frequency of tumour necrosis factor alpha receptor superfamily 1A multiple sclerosis-associated variants in patients with rheumatoid arthritis with anti-tumour necrosis factor therapy-related demyelinating complications. Annals of the Rheumatic Diseases. PMID 30030263 DOI: 10.1136/Annrheumdis-2018-213183  0.84
2018 Bitoun S, Nocturne G, Ly B, Krzysiek R, Roques P, Pruvost A, Paoletti A, Pascaud J, Dönnes P, Florence K, Gleizes A, Hincelin-Mery A, Allez M, Hacein-Bey-Abina S, Mackay F, ... ... Mariette X, et al. Methotrexate and BAFF interaction prevents immunization against TNF inhibitors. Annals of the Rheumatic Diseases. PMID 29936438 DOI: 10.1136/Annrheumdis-2018-213403  1
2018 Rivière E, Sellam J, Pascaud J, Ravaud P, Gottenberg JE, Mariette X. Serum IL-33 level is associated with auto-antibodies but not with clinical response to biologic agents in rheumatoid arthritis. Arthritis Research & Therapy. 20: 122. PMID 29884223 DOI: 10.1186/S13075-018-1628-6  0.68
2018 Michot JM, Fusellier M, Champiat S, Velter C, Baldini C, Voisin AL, Danlos FX, Dakdouki YE, Annereau M, Mariette X, Robert C, Cherif K, Marabelle A, Mateus C, Lambotte O. Drug-induced lupus erythematosus following immunotherapy with anti-programmed death-(ligand) 1. Annals of the Rheumatic Diseases. PMID 29858173 DOI: 10.1136/Annrheumdis-2018-213677  0.52
2018 Freund R, Granger B, Francois C, Carcelain G, Ravaud P, Mariette X, Fautrel B. Cost-effectiveness analysis of strategies using new immunological diagnostic tests of latent tuberculosis infection before TNF-blockers therapy. Presse Medicale (Paris, France : 1983). PMID 29478790 DOI: 10.1016/J.Lpm.2017.09.029  0.4
2018 Demaria L, Henry J, Seror R, Frenzel L, Hermine O, Mariette X, Nocturne G. Rituximab-Bendamustine (R-Benda) in MALT lymphoma complicating primary Sjögren syndrome (pSS). British Journal of Haematology. PMID 29424433 DOI: 10.1111/Bjh.15120  1
2018 Nocturne G, Mariette X. B cells in the pathogenesis of primary Sjögren syndrome. Nature Reviews. Rheumatology. PMID 29416129 DOI: 10.1038/Nrrheum.2018.1  1
2018 Gottenberg JE, Dörner T, Bootsma H, Devauchelle-Pensec V, Bowman SJ, Mariette X, Bartz H, Oortgiesen M, Shock A, Koetse W, Galateanu C, Bongardt S, Wegener WA, Goldenberg DM, Meno-Tetang G, et al. Efficacy of Epratuzumab, an Anti-CD22 Monoclonal IgG Antibody, in Systemic Lupus Erythematosus Patients with Associated Sjögren's Syndrome: Post-hoc Analyses from the EMBODY Trials. Arthritis & Rheumatology (Hoboken, N.J.). PMID 29381843 DOI: 10.1002/Art.40425  0.64
2018 Rivière E, Tchitchek N, Nocturne G, Pascaud J, Boudaoud S, Thai A, Allaire N, Jagla B, Mingueneau M, Mariette X. P071/O13 RNA sequencing detection of gene dysregulation in B cells sorted from salivary gland tissue and from peripheral blood reveals new pathways involved in primary sjÖgren’s syndrome pathophysiology Annals of the Rheumatic Diseases. 77: 138-138. DOI: 10.1136/Annrheumdis-2018-Ewrr2019.60  1
2018 Bitoun S, Nocturne G, Ly B, Krzysiek R, Pruvost A, Paoletti A, Pascaud J, Dönnes P, Florence K, Gleizes A, Hincelin-Mery A, Allez M, Bey SH, Pallardy M, Mariette X. P008 Methotrexate and baff interaction prevents immunisation against TNF-Α inhibitors by increasing adenosine and regulatory B-cells Annals of the Rheumatic Diseases. 77. DOI: 10.1136/Annrheumdis-2018-Ewrr2018.34  1
2018 Virone A, Pascaud J, Riviere E, Gottenberg J, Guern VL, Mariette X, Nocturne G. O017 Il-7 in primary sjÖgren syndrome (PSS) is secreted by salivary gland epithelial cells after ifn stimulation and is associated with B-cell activation Annals of the Rheumatic Diseases. 77. DOI: 10.1136/Annrheumdis-2018-Ewrr2018.17  1
2018 Aringer M, Costenbader KH, Brinks R, Boumpas D, Daikh D, Jayne D, Kamen D, Mosca M, Ramsey-Goldman R, Smolen JS, Wofsy D, Diamond B, Jacobsen S, McCune WJ, Ruiz-Irastorza G, ... ... Mariette X, et al. OP0020 Validation of new systemic lupus erythematosus classification criteria Annals of the Rheumatic Diseases. 77: 60-60. DOI: 10.1136/Annrheumdis-2018-Eular.3679  0.76
2018 Rivière E, Tchitchek N, Nocturne G, Boudaoud S, Pascaud J, Virone A, Thai A, Allaire N, Jagla B, Mingueneau M, Mariette X. FRI0273 Rna sequencing detection of gene dysregulation in epithelial sorted cells from salivary gland tissue reveals interesting pathways involved in sjÖgren’s syndrome pathophysiology Annals of the Rheumatic Diseases. 77: 675-675. DOI: 10.1136/Annrheumdis-2018-Eular.3307  1
2017 Bitoun S, Roques P, Larcher T, Nocturne G, Serguera C, Chrétien P, Serre G, Grand RL, Mariette X. Both Systemic and Intra-articular Immunization with Citrullinated Peptides Are Needed to Induce Arthritis in the Macaque. Frontiers in Immunology. 8: 1816. PMID 29326703 DOI: 10.3389/Fimmu.2017.01816  1
2017 Urbina T, Belkhir R, Rossi G, Carbonnel F, Pavy S, Collins M, Mariette X, Seror R. Iron supplementation induced phosphaturic osteomalacia: FGF23 is the culprit Comment on the paper by Bartko J. et al. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. PMID 29281120 DOI: 10.1002/Jbmr.3369  0.76
2017 Henry J, Gottenberg JE, Rouanet S, Pavy S, Sellam J, Tubach F, Belkhir R, Mariette X, Seror R. Doses of rituximab for retreatment in rheumatoid arthritis: influence on maintenance and risk of serious infection. Rheumatology (Oxford, England). PMID 29267905 DOI: 10.1093/Rheumatology/Kex446  0.76
2017 Harris VM, Sharma R, Cavett J, Kurien BT, Liu K, Koelsch KA, Rasmussen A, Radfar L, Lewis D, Stone DU, Kaufman CE, Li S, Segal B, Wallace DJ, Weisman MH, ... ... Mariette X, et al. Corrigendum to "Klinefelter's syndrome (47,XXY) is in excess among men with Sjögren's syndrome" [Clin. Immunol. 168 (2016) 25-29]. Clinical Immunology (Orlando, Fla.). PMID 29195081 DOI: 10.1016/J.Clim.2017.11.012  0.84
2017 Nourisson C, Soubrier M, Mulliez A, Baillet A, Bardin T, Cantagrel A, Combe B, Dougados M, Flipo RM, Schaeverbeke T, Sibilia J, Vittecoq O, Ravaud P, Gottenberg JE, Mariette X, et al. Impact of gender on the response and tolerance to abatacept in patients with rheumatoid arthritis: results from the 'ORA' registry. Rmd Open. 3: e000515. PMID 29177081 DOI: 10.1136/Rmdopen-2017-000515  0.64
2017 Juge PA, Gazal S, Constantin A, Mariette X, Combe B, Tebib J, Dougados M, Sibilia J, Le Loet X, Dieudé P. Variants of genes implicated in type 1 interferon pathway and B-cell activation modulate the EULAR response to rituximab at 24 weeks in rheumatoid arthritis. Rmd Open. 3: e000448. PMID 29071117 DOI: 10.1136/Rmdopen-2017-000448  0.6
2017 Salmon JH, Perotin JM, Morel J, Dramé M, Cantagrel A, Ziegler LE, Ravaud P, Sibilia J, Pane I, Mariette X, Gottenberg JE. Serious infusion-related reaction after rituximab, abatacept and tocilizumab in rheumatoid arthritis: prospective registry data. Rheumatology (Oxford, England). PMID 29069471 DOI: 10.1093/Rheumatology/Kex403  0.64
2017 Seror R, Mariette X. Guidelines for treatment of primary Sjögren's syndrome: a first useful stone but still much to do. Rheumatology (Oxford, England). 56: 1641-1642. PMID 28957571 DOI: 10.1093/Rheumatology/Kex320  0.76
2017 Morel J, Constantin A, Baron G, Dernis E, Flipo RM, Rist S, Combe B, Gottenberg JE, Schaeverbeke T, Soubrier M, Vittecoq O, Dougados M, Saraux A, Mariette X, Ravaud P, et al. Risk factors of serious infections in patients with rheumatoid arthritis treated with tocilizumab in the French Registry REGATE. Rheumatology (Oxford, England). 56: 1746-1754. PMID 28957557 DOI: 10.1093/Rheumatology/Kex238  0.64
2017 Sigaux J, Bailly F, Hajage D, Mariette X, Morel J, Gandjbakhch F, Foltz V, Gossec L, Tubach F, Fautrel B. Sustainability of TNF-blocker tapering in rheumatoid arthritis over 3 years: long-term follow-up of the STRASS (Spacing of TNF-blocker injections in Rheumatoid ArthritiS Study) randomised controlled trial. Rmd Open. 3: e000474. PMID 28955495 DOI: 10.1136/Rmdopen-2017-000474  0.44
2017 Wang-Renault SF, Boudaoud S, Nocturne G, Roche E, Sigrist N, Daviaud C, Bugge Tinggaard A, Renault V, Deleuze JF, Mariette X, Tost J. Deregulation of microRNA expression in purified T and B lymphocytes from patients with primary Sjögren's syndrome. Annals of the Rheumatic Diseases. PMID 28916716 DOI: 10.1136/Annrheumdis-2017-211417  1
2017 Fogel O, Rivière E, Seror R, Nocturne G, Boudaoud S, Ly B, Gottenberg JE, Le Guern V, Dubost JJ, Nititham J, Taylor KE, Chanson P, Dieudé P, Criswell LA, Jagla B, ... ... Mariette X, et al. Role of the IL-12/IL-35 balance in Sjögren's syndrome. The Journal of Allergy and Clinical Immunology. PMID 28916184 DOI: 10.1016/J.Jaci.2017.07.041  1
2017 Mercer LK, Regierer AC, Mariette X, Dixon WG, Baecklund E, Hellgren K, Dreyer L, Hetland ML, Cordtz R, Hyrich K, Strangfeld A, Zink A, Canhao H, Hernandez MV, Tubach F, et al. Spectrum of lymphomas across different drug treatment groups in rheumatoid arthritis: a European registries collaborative project. Annals of the Rheumatic Diseases. PMID 28822981 DOI: 10.1136/Annrheumdis-2017-211623  0.64
2017 Sharma R, Harris VM, Cavett J, Kurien BT, Liu K, Koelsch KA, Fayaaz A, Chaudhari KS, Radfar L, Lewis D, Stone DU, Kaufman CE, Li S, Segal B, Wallace DJ, ... ... Mariette X, et al. Rare X chromosome abnormalities in systemic lupus erythematosus and Sjögren's syndrome. Arthritis & Rheumatology (Hoboken, N.J.). PMID 28692793 DOI: 10.1002/Art.40207  0.84
2017 Le Burel S, Champiat S, Mateus C, Marabelle A, Michot JM, Robert C, Belkhir R, Soria JC, Laghouati S, Voisin AL, Fain O, Mékinian A, Coutte L, Szwebel TA, Dunogeant L, ... ... Mariette X, et al. Prevalence of immune-related systemic adverse events in patients treated with anti-Programmed cell Death 1/anti-Programmed cell Death-Ligand 1 agents: A single-centre pharmacovigilance database analysis. European Journal of Cancer (Oxford, England : 1990). 82: 34-44. PMID 28646772 DOI: 10.1016/J.Ejca.2017.05.032  0.52
2017 Li H, Reksten TR, Ice JA, Kelly JA, Adrianto I, Rasmussen A, Wang S, He B, Grundahl KM, Glenn SB, Miceli-Richard C, Bowman S, Lester S, Eriksson P, Eloranta ML, ... ... Mariette X, et al. Identification of a Sjögren's syndrome susceptibility locus at OAS1 that influences isoform switching, protein expression, and responsiveness to type I interferons. Plos Genetics. 13: e1006820. PMID 28640813 DOI: 10.1371/Journal.Pgen.1006820  0.84
2017 Belkhir R, Burel SL, Dunogeant L, Marabelle A, Hollebecque A, Besse B, Leary A, Voisin AL, Pontoizeau C, Coutte L, Pertuiset E, Mouterde G, Fain O, Lambotte O, Mariette X. Rheumatoid arthritis and polymyalgia rheumatica occurring after immune checkpoint inhibitor treatment. Annals of the Rheumatic Diseases. PMID 28600350 DOI: 10.1136/Annrheumdis-2017-211216  0.52
2017 Hamze M, Meunier S, Karle A, Gdoura A, Goudet A, Szely N, Pallardy M, Carbonnel F, Spindeldreher S, Mariette X, Miceli-Richard C, Maillère B. Characterization of CD4 T Cell Epitopes of Infliximab and Rituximab Identified from Healthy Donors. Frontiers in Immunology. 8: 500. PMID 28529511 DOI: 10.3389/Fimmu.2017.00500  0.84
2017 Kleinmann JF, Tubach F, Le Guern V, Mathian A, Richez C, Saadoun D, Sacre K, Sellam J, Seror R, Amoura Z, Andres E, Audia S, Bader-Meunier B, Blaison G, Bonnotte B, ... ... Mariette X, et al. International and multidisciplinary expert recommendations for the use of biologics in systemic lupus erythematosus. Autoimmunity Reviews. PMID 28434948 DOI: 10.1016/J.Autrev.2017.04.011  0.76
2017 Rivière E, Arnaud L, Ebbo M, Allanore Y, Claudepierre P, Dernis E, Ziza JM, Miceli-Richard C, Philippe P, Richez C, Soubrier M, Belkhir R, Seror R, Mariette X, Pavy S, et al. Takayasu Arteritis and Spondyloarthritis: Coincidence or Association? A Study of 14 Cases. The Journal of Rheumatology. PMID 28412700 DOI: 10.3899/Jrheum.160762  0.84
2017 Vanier A, Mariette X, Tubach F, Fautrel B. Cost-Effectiveness of TNF-Blocker Injection Spacing for Patients with Established Rheumatoid Arthritis in Remission: An Economic Evaluation from the Spacing of TNF-Blocker Injections in Rheumatoid Arthritis Trial. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 20: 577-585. PMID 28407999 DOI: 10.1016/J.Jval.2017.01.005  0.44
2017 Lopez A, Mariette X, Bachelez H, Belot A, Bonnotte B, Hachulla E, Lahfa M, Lortholary O, Loulergue P, Paul S, Roblin X, Sibilia J, Blum M, Danese S, Bonovas S, et al. Vaccination recommendations for the adult immunosuppressed patient: A systematic review and comprehensive field synopsis. Journal of Autoimmunity. PMID 28381345 DOI: 10.1016/J.Jaut.2017.03.011  0.6
2017 Carapito R, Gottenberg JE, Kotova I, Untrau M, Michel S, Naegely L, Aouadi I, Kwemou M, Paul N, Pichot A, Locke J, Bowman SJ, Griffiths B, Sivils KL, Sibilia J, ... ... Mariette X, et al. A new MHC-linked susceptibility locus for primary Sjögren's syndrome: MICA. Human Molecular Genetics. PMID 28379387 DOI: 10.1093/Hmg/Ddx135  1
2017 de Jong TD, Sellam J, Agca R, Vosslamber S, Witte BI, Tsang-A-Sjoe M, Mantel E, Bijlsma JW, Voskuyl AE, Nurmohamed MT, Verweij CL, Mariette X. A multi-parameter response prediction model for rituximab in rheumatoid arthritis. Joint, Bone, Spine : Revue Du Rhumatisme. PMID 28363827 DOI: 10.1016/J.Jbspin.2017.02.015  0.68
2017 Smolen JS, Landewé R, Bijlsma J, Burmester G, Chatzidionysiou K, Dougados M, Nam J, Ramiro S, Voshaar M, van Vollenhoven R, Aletaha D, Aringer M, Boers M, Buckley CD, Buttgereit F, ... ... Mariette X, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Annals of the Rheumatic Diseases. PMID 28264816 DOI: 10.1136/Annrheumdis-2016-210715  0.64
2017 Vitali C, Scofield H, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM, Rasmussen A, Bowman SJ, Mariette X, Shiboski CH. Authors' Response to Tezcan and Colleagues' Letter to the Editor. Arthritis & Rheumatology (Hoboken, N.J.). PMID 28257605 DOI: 10.1002/Art.40085  0.76
2017 Le Burel S, Champiat S, Routier E, Aspeslagh S, Albiges L, Szwebel TA, Michot JM, Chretien P, Mariette X, Voisin AL, Lambotte O. Onset of connective tissue disease following anti-PD1/PD-L1 cancer immunotherapy. Annals of the Rheumatic Diseases. PMID 28242618 DOI: 10.1136/Annrheumdis-2016-210820  0.52
2017 Nocturne G, Seror R, Devauchelle-Pensec V, Saraux A, Mariette X, Chiche L. Prevalence of primary Sjögren Syndrome: What if Sjögren was right after all? Arthritis Care & Research. PMID 28217861 DOI: 10.1002/Acr.23223  1
2017 Nocturne G, Boudaoud S, Ly B, Pascaud J, Paoletti A, Mariette X. Impact of anti-TNF therapy on NK cells function and on immunosurveillance against B-cell lymphomas. Journal of Autoimmunity. PMID 28214146 DOI: 10.1016/J.Jaut.2017.02.001  1
2017 Seror R, Mariette X. Cost-effectiveness of rituximab strategies in rheumatoid arthritis. Lancet (London, England). 389: 365-366. PMID 28137690 DOI: 10.1016/S0140-6736(17)30053-3  0.76
2017 Sellam J, Rivière E, Courties A, Rouzaire PO, Tolusso B, Vital EM, Emery P, Ferracioli G, Soubrier M, Ly B, Chavez HH, Taoufik Y, Dougados M, Mariette X. Erratum to: Serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritis. Arthritis Research & Therapy. 19: 11. PMID 28115013 DOI: 10.1186/S13075-017-1221-4  0.68
2017 Latourte A, Gottenberg JE, Luxembourger C, Pane I, Claudepierre P, Richette P, Lafforgue P, Combe B, Cantagrel A, Sibilia J, Flipo RM, Gaudin P, Vittecoq O, Schaeverbeke T, Dougados M, ... ... Mariette X, et al. Safety of surgery in patients with rheumatoid arthritis treated by abatacept: data from the French Orencia in Rheumatoid Arthritis Registry. Rheumatology (Oxford, England). PMID 28053274 DOI: 10.1093/Rheumatology/Kew476  0.76
2017 Seror R, Mariette X. Malignancy and the Risks of Biologic Therapies: Current Status. Rheumatic Diseases Clinics of North America. 43: 43-64. PMID 27890173 DOI: 10.1016/J.Rdc.2016.09.006  0.76
2017 Nocturne G, Seror R, Mariette X. Does the risk of lymphoma in patients with RA treated with TNF inhibitors differ according to the histological subtype and the type of TNF inhibitor? Annals of the Rheumatic Diseases. 76: e3. PMID 27742658 DOI: 10.1136/Annrheumdis-2016-210566  1
2017 Nocturne G, Ly B, Boudaoud S, Bitoun S, Paoletti A, Seror R, Nicco C, Mackay F, Vincent F, Ferlicot S, Stimmer L, Roulland S, krzysiek R, Bey SH, Batteux F, ... Mariette X, et al. P028 Treatment of BAFF transgenic mice with ANTI-TNF: monoclonal ANTI-TNF are associated with a higher risk of lymphoma than etanercept Annals of the Rheumatic Diseases. 76: 182-183. DOI: 10.1136/Annrheumdis-2018-Ewrr2018.52  1
2017 Belkhir R, Burel SL, Lambotte O, Mouterde G, Pertuiset E, Dunogeant L, Marabelle A, Leary A, Voisin A, Mariette X. OP0004 Rheumatoid arthritis occuring after immune checkpoint inhibitors Annals of the Rheumatic Diseases. 76: 51-52. DOI: 10.1136/Annrheumdis-2017-Eular.3768  0.52
2017 Bitoun S, Roques P, Larcher T, Nocturne G, Serguera C, Chrétien P, Serre G, Grand RL, Mariette X. FRI0081 A macaque model of rheumatoid arthritis by immunization with citrullinated peptides: lessons for the human disease Annals of the Rheumatic Diseases. 76. DOI: 10.1136/Annrheumdis-2017-Eular.2843  1
2017 Jong TDd, Sellam J, Agca R, Vosslamber S, Witte BI, Tsang-a-Sjoe M, Mantel E, Bijlsma JW, Voskuyl AE, Nurmohamed MT, Verweij CL, Mariette X. 07.01 A multi-parameter response prediction model for rituximab in rheumatoid arthritis Annals of the Rheumatic Diseases. DOI: 10.1136/Annrheumdis-2016-211054.1  0.68
2016 Iannone F, Courvoisier DS, Gottenberg JE, Hernandez MV, Lie E, Canhão H, Pavelka K, Hetland ML, Turesson C, Mariette X, Choquette D, Finckh A. Body mass does not impact the clinical response to intravenous abatacept in patients with rheumatoid arthritis. Analysis from the "pan-European registry collaboration for abatacept (PANABA). Clinical Rheumatology. PMID 27966068 DOI: 10.1007/S10067-016-3505-5  0.64
2016 Fisher BA, Jonsson R, Daniels T, Bombardieri M, Brown RM, Morgan P, Bombardieri S, Ng WF, Tzioufas AG, Vitali C, Shirlaw P, Haacke E, Costa S, Bootsma H, Devauchelle-Pensec V, ... ... Mariette X, et al. Standardisation of labial salivary gland histopathology in clinical trials in primary Sjögren's syndrome. Annals of the Rheumatic Diseases. PMID 27965259 DOI: 10.1136/Annrheumdis-2016-210448  0.4
2016 Sellam J, Rivière E, Courties A, Rouzaire PO, Tolusso B, Vital EM, Emery P, Ferraciolli G, Soubrier M, Ly B, Hendel Chavez H, Taoufik Y, Dougados M, Mariette X. Serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritis. Arthritis Research & Therapy. 18: 294. PMID 27964756 DOI: 10.1186/S13075-016-1190-Z  0.68
2016 Jasiek M, Karras A, Le Guern V, Krastinova E, Mesbah R, Faguer S, Jourde-Chiche N, Fauchais AL, Chiche L, Dernis E, Moulis G, Fraison JB, Lazaro E, Jullien P, Hachulla E, ... ... Mariette X, et al. A multicentre study of 95 biopsy-proven cases of renal disease in primary Sjögren's syndrome. Rheumatology (Oxford, England). PMID 27940588 DOI: 10.1093/Rheumatology/Kew376  0.76
2016 Portier A, Gossec L, Tubach F, Alfaiate T, Pham T, Saraux A, Soubrier M, Schaeverbeke T, Maillefert JF, Mariette X, Hajage D, Fautrel B. Patient-perceived flares in rheumatoid arthritis: A sub-analysis of the STRASS treatment tapering strategy trial. Joint, Bone, Spine : Revue Du Rhumatisme. PMID 27932278 DOI: 10.1016/J.Jbspin.2016.10.001  0.44
2016 Brito-Zerón P, Acar-Denizli N, Zeher M, Rasmussen A, Seror R, Theander E, Li X, Baldini C, Gottenberg JE, Danda D, Quartuccio L, Priori R, Hernandez-Molina G, Kruize AA, Valim V, ... ... Mariette X, et al. Influence of geolocation and ethnicity on the phenotypic expression of primary Sjögren's syndrome at diagnosis in 8310 patients: a cross-sectional study from the Big Data Sjögren Project Consortium. Annals of the Rheumatic Diseases. PMID 27899373 DOI: 10.1136/Annrheumdis-2016-209952  0.76
2016 Zhao L, Nocturne G, Haskett S, Boudaoud S, Lazure T, Le Pajolec C, Mariette X, Mingueneau M, Banerjee D. Clinical relevance of RORγ positive and negative subsets of CD161+CD4+ T cells in primary Sjögren's syndrome. Rheumatology (Oxford, England). PMID 27803305 DOI: 10.1093/Rheumatology/Kew360  1
2016 Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM, Rasmussen A, Scofield H, Vitali C, Bowman SJ, Mariette X. 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren's syndrome A consensus and data-driven methodology involving three international patient cohorts. Annals of the Rheumatic Diseases. PMID 27789466 DOI: 10.1136/Annrheumdis-2016-210571  0.76
2016 Cui J, Diogo D, Stahl EA, Canhao H, Mariette X, Greenberg JD, Okada Y, Pappas DA, Fulton RS, Tak PP, Nurmohamed MT, Lee A, Larson DE, Kurreeman F, Deluca TL, et al. The role of rare protein-coding variants to anti-TNF treatment response in rheumatoid arthritis. Arthritis & Rheumatology (Hoboken, N.J.). PMID 27788309 DOI: 10.1002/Art.39966  0.84
2016 Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM, Rasmussen A, Scofield H, Vitali C, Bowman SJ, Mariette X. 2016 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Primary Sjögren's Syndrome: A Consensus and Data-Driven Methodology Involving Three International Patient Cohorts. Arthritis & Rheumatology (Hoboken, N.J.). PMID 27785888 DOI: 10.1002/Art.39859  0.76
2016 Gottenberg JE, Brocq O, Perdriger A, Lassoued S, Berthelot JM, Wendling D, Euller-Ziegler L, Soubrier M, Richez C, Fautrel B, Constantin AL, Mariette X, Morel J, Gilson M, Cormier G, et al. Non-TNF-Targeted Biologic vs a Second Anti-TNF Drug to Treat Rheumatoid Arthritis in Patients With Insufficient Response to a First Anti-TNF Drug: A Randomized Clinical Trial. Jama. 316: 1172-1180. PMID 27654603 DOI: 10.1001/Jama.2016.13512  0.68
2016 Rydén-Aulin M, Boumpas D, Bultink I, Callejas Rubio JL, Caminal-Montero L, Castro A, Colodro Ruiz A, Doria A, Dörner T, Gonzalez-Echavarri C, Gremese E, Houssiau FA, Huizinga T, Inanç M, Isenberg D, ... ... Mariette X, et al. Off-label use of rituximab for systemic lupus erythematosus in Europe. Lupus Science & Medicine. 3: e000163. PMID 27651920 DOI: 10.1136/Lupus-2016-000163  0.68
2016 Courvoisier DS, Alpizar-Rodriguez D, Gottenberg JE, Hernandez MV, Iannone F, Lie E, Santos MJ, Pavelka K, Turesson C, Mariette X, Choquette D, Hetland ML, Finckh A. Rheumatoid Arthritis Patients after Initiation of a New Biologic Agent: Trajectories of Disease Activity in a Large Multinational Cohort Study. Ebiomedicine. PMID 27558858 DOI: 10.1016/J.Ebiom.2016.08.024  0.64
2016 Nocturne G, Cornec D, Seror R, Mariette X. Use of Biologics in Sjögren's Syndrome. Rheumatic Diseases Clinics of North America. 42: 407-17. PMID 27431344 DOI: 10.1016/J.Rdc.2016.03.001  1
2016 Cornec D, Devauchelle-Pensec V, Mariette X, Jousse-Joulin S, Berthelot JM, Perdriger A, Puéchal X, Le Guern V, Sibilia J, Gottenberg JE, Chiche L, Hachulla E, Hatron PY, Goeb V, Hayem G, et al. Severe Health-Related Quality-of-life Impairment in Active Primary Sjögren's Syndrome Is Driven by Patient-Reported Outcomes: Data from a Large Therapeutic Trial. Arthritis Care & Research. PMID 27390310 DOI: 10.1002/Acr.22974  0.76
2016 Sigaux J, Hamze M, Daien C, Morel J, Krzysiek R, Pallardy M, Maillere B, Mariette X, Miceli-Richard C. Immunogenicity of tocilizumab in patients with rheumatoid arthritis. Joint, Bone, Spine : Revue Du Rhumatisme. PMID 27369643 DOI: 10.1016/J.Jbspin.2016.04.013  0.84
2016 Desbois AC, Addimanda O, Bertrand A, Deroux A, Pérard L, Depaz R, Hachulla E, Lambert M, Launay D, Subran B, Ackerman F, Mariette X, Cohen F, Marie I, Salvarini C, et al. Efficacy of Anti-TNFα in Severe and Refractory Neuro-Behcet Disease: An Observational Study. Medicine. 95: e3550. PMID 27281066 DOI: 10.1097/Md.0000000000003550  0.68
2016 Seror R, Meiners P, Baron G, Bootsma H, Bowman SJ, Vitali C, Gottenberg JE, Theander E, Tzioufas A, De Vita S, Ramos-Casals M, Dörner T, Quartuccio L, Ravaud P, Mariette X, et al. Development of the ClinESSDAI: a clinical score without biological domain. A tool for biological studies. Annals of the Rheumatic Diseases. PMID 27150113 DOI: 10.1136/Annrheumdis-2015-208504  0.76
2016 Carvajal Alegria G, Guellec D, Mariette X, Gottenberg JE, Dernis E, Dubost JJ, Trouvin AP, Hachulla E, Larroche C, Le Guern V, Cornec D, Devauchelle-Pensec V, Saraux A. Epidemiology of neurological manifestations in Sjögren's syndrome: data from the French ASSESS Cohort. Rmd Open. 2: e000179. PMID 27110384 DOI: 10.1136/Rmdopen-2015-000179  0.64
2016 Harris VM, Sharma R, Cavett J, Kurien BT, Liu K, Koelsch KA, Rasmussen A, Radfar L, Lewis D, Stone DU, Kaufman CE, Li S, Segal B, Wallace DJ, Weisman MH, ... ... Mariette X, et al. Klinefelter's syndrome (47,XXY) is in excess among men with Sjögren's syndrome. Clinical Immunology (Orlando, Fla.). PMID 27109640 DOI: 10.1016/J.Clim.2016.04.002  0.68
2016 Vincent FB, Pavy S, Krzysiek R, Lequerré T, Sellam J, Taoufik Y, Mariette X, Miceli-Richard C. Effect of serum anti-tumour necrosis factor (TNF) drug trough concentrations and antidrug antibodies (ADAb) to further anti-TNF short-term effectiveness after switching in rheumatoid arthritis and axial spondyloarthritis. Joint, Bone, Spine : Revue Du Rhumatisme. PMID 27066773 DOI: 10.1016/J.Jbspin.2015.07.015  0.84
2016 Mingueneau M, Boudaoud S, Haskett S, Reynolds TL, Nocturne G, Norton E, Zhang X, Constant M, Park D, Wang W, Lazure T, Le Pajolec C, Ergun A, Mariette X. Cytometry by time-of-flight immunophenotyping identifies a blood Sjögren's signature correlating with disease activity and glandular inflammation. The Journal of Allergy and Clinical Immunology. PMID 27045581 DOI: 10.1016/J.Jaci.2016.01.024  0.68
2016 Strehl C, Bijlsma JW, de Wit M, Boers M, Caeyers N, Cutolo M, Dasgupta B, Dixon WG, Geenen R, Huizinga TW, Kent A, de Thurah AL, Listing J, Mariette X, Ray DW, et al. Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force. Annals of the Rheumatic Diseases. PMID 26933146 DOI: 10.1136/Annrheumdis-2015-208916  0.68
2016 Lahaye C, Soubrier M, Mulliez A, Bardin T, Cantagrel A, Combe B, Dougados M, Flipo RM, Le Loët X, Shaeverbeke T, Ravaud P, Mariette X, Gottenberg JE. Effectiveness and safety of abatacept in elderly patients with rheumatoid arthritis enrolled in the French Society of Rheumatology's ORA registry. Rheumatology (Oxford, England). 55: 874-82. PMID 26822072 DOI: 10.1093/Rheumatology/Kev437  0.64
2016 Gottenberg JE, Courvoisier DS, Hernandez MV, Iannone F, Lie E, Canhão H, Pavelka K, Hetland ML, Turesson C, Mariette X, Finckh A. Rheumatoid factor and anti-citrullinated protein antibody positivity are associated with a better effectiveness of abatacept: Results from the Pan-European registry analysis. Arthritis & Rheumatology (Hoboken, N.J.). PMID 26815727 DOI: 10.1002/Art.39595  0.64
2016 Seror R, Boudaoud S, Pavy S, Nocturne G, Schaeverbeke T, Saraux A, Chanson P, Gottenberg JE, Devauchelle-Pensec V, Tobón GJ, Mariette X, Miceli-Richard C. Increased Dickkopf-1 in Recent-onset Rheumatoid Arthritis is a New Biomarker of Structural Severity. Data from the ESPOIR Cohort. Scientific Reports. 6: 18421. PMID 26785768 DOI: 10.1038/Srep18421  1
2016 Nocturne G, Seror R, Mariette X. Reply. Arthritis & Rheumatology (Hoboken, N.J.). 68: 1319-20. PMID 26749273 DOI: 10.1002/Art.39584  1
2016 Rivière E, Ly B, Boudaoud S, Chavez H, Nocturne G, Chanson P, Miceli Richard C, Mariette X. Pitfalls for detecting interleukin-33 by ELISA in the serum of patients with primary Sjögren syndrome: comparison of different kits. Annals of the Rheumatic Diseases. 75: 633-5. PMID 26659716 DOI: 10.1136/Annrheumdis-2015-208557  1
2016 Tomi AL, Belkhir R, Nocturne G, Desmoulins F, Berge E, Pavy S, Miceli-Richard C, Mariette X, Seror R. Brief Report: Monoclonal Gammopathy and Risk of Lymphoma and Multiple Myeloma in Patients With Primary Sjögren's Syndrome. Arthritis & Rheumatology (Hoboken, N.J.). 68: 1245-50. PMID 26636425 DOI: 10.1002/Art.39534  1
2016 Danlos FX, Daoued-Keffi F, Rohmer J, Cluzel G, Blanc-Autran E, François H, Lazure T, Seror R, Mariette X. IgG4-related disease associated with renal microaneurysms and polycythaemia. Rheumatology (Oxford, England). 55: 380-2. PMID 26464522 DOI: 10.1093/Rheumatology/Kev365  0.76
2016 Miceli-Richard C, Wang-Renault SF, Boudaoud S, Busato F, Lallemand C, Bethune K, Belkhir R, Nocturne G, Mariette X, Tost J. Overlap between differentially methylated DNA regions in blood B lymphocytes and genetic at-risk loci in primary Sjögren's syndrome. Annals of the Rheumatic Diseases. 75: 933-40. PMID 26183421 DOI: 10.1136/Annrheumdis-2014-206998  1
2016 Fautrel B, Pham T, Alfaiate T, Gandjbakhch F, Foltz V, Morel J, Dernis E, Gaudin P, Brocq O, Solau-Gervais E, Berthelot JM, Balblanc JC, Mariette X, Tubach F. Step-down strategy of spacing TNF-blocker injections for established rheumatoid arthritis in remission: results of the multicentre non-inferiority randomised open-label controlled trial (STRASS: Spacing of TNF-blocker injections in Rheumatoid ArthritiS Study). Annals of the Rheumatic Diseases. 75: 59-67. PMID 26103979 DOI: 10.1136/Annrheumdis-2014-206696  0.44
2016 Salmon JH, Gottenberg JE, Ravaud P, Cantagrel A, Combe B, Flipo RM, Schaeverbeke T, Houvenagel E, Gaudin P, Loeuille D, Rist S, Dougados M, Sibilia J, Le Loët X, Meyer O, ... ... Mariette X, et al. Predictive risk factors of serious infections in patients with rheumatoid arthritis treated with abatacept in common practice: results from the Orencia and Rheumatoid Arthritis (ORA) registry. Annals of the Rheumatic Diseases. 75: 1108-1113. PMID 26048170 DOI: 10.1136/Annrheumdis-2015-207362  0.68
2016 Morel J, Constantin A, Dernis E, Rist S, Flipo RM, Schaeverbeke T, Vittecoq O, Soubrier M, Saraux A, Combe B, Dougados M, Pinta A, Baron G, Gottenberg J-, Mariette X, et al. FRI0219 Risk Factors of Severe Infections in Patients with Rheumatoid Arthritis Treated with Tocilizumab in The French Registry Regate (Registry –Roactemra) Annals of the Rheumatic Diseases. 75: 511-511. DOI: 10.1136/Annrheumdis-2016-Eular.3249  0.6
2016 Rivière E, Ly B, Boudaoud S, Chavez H, Nocturne G, Chanson P, Richard CM, Mariette X. Pitfalls for detecting interleukin-33 by ELISA in the serum of patients with primary Sjögren syndrome: Comparison of different kits Annals of the Rheumatic Diseases. 75: 633-635. DOI: 10.1136/annrheumdis-2015-208557  0.68
2016 Seror R, Meiners P, Baron G, Bootsma H, Bowman SJ, Vitali C, Gottenberg JE, Theander E, Tzioufas A, De Vita S, Ramos-Casals M, Dörner T, Quartuccio L, Ravaud P, Mariette X, et al. Development of the ClinESSDAI: A clinical score without biological domain. A tool for biological studies Annals of the Rheumatic Diseases. DOI: 10.1136/annrheumdis-2015-208504  0.68
2015 Nocturne G, Cornec D, Seror R, Mariette X. New biological therapies in Sjögren's syndrome. Best Practice & Research. Clinical Rheumatology. 29: 783-93. PMID 27107513 DOI: 10.1016/J.Berh.2016.02.009  1
2015 Liu K, Kurien BT, Zimmerman SL, Kaufman KM, Taft DH, Kottyan LC, Lazaro S, Weaver CA, Ice JA, Adler AJ, Chodosh J, Radfar L, Rasmussen A, Stone DU, Lewis DM, ... ... Mariette X, et al. X Chromosome Dose and Sex Bias in Autoimmune Diseases: Increased 47,XXX in Systemic Lupus Erythematosus and Sjögren's Syndrome. Arthritis & Rheumatology (Hoboken, N.J.). PMID 26713507 DOI: 10.1002/Art.39560  0.68
2015 Brito-Zerón P, Theander E, Baldini C, Seror R, Retamozo S, Quartuccio L, Bootsma H, Bowman SJ, Dörner T, Gottenberg JE, Mariette X, Bombardieri S, de Vita S, Mandl T, Ng WF, et al. Early diagnosis of primary Sjögren's syndrome: EULAR-SS task force clinical recommendations. Expert Review of Clinical Immunology. 1-20. PMID 26691952 DOI: 10.1586/1744666X.2016.1109449  0.68
2015 Rivoisy C, Tubach F, Roy C, Nicolas N, Mariette X, Salmon D, Lortholary O, Bourgarit A. Paradoxical anti-TNF-associated TB worsening: Frequency and factors associated with IRIS. Joint, Bone, Spine : Revue Du Rhumatisme. PMID 26677996 DOI: 10.1016/J.Jbspin.2015.04.022  0.68
2015 Nocturne G, Virone A, Ng WF, Le Guern V, Hachulla E, Cornec D, Daien C, Vittecoq O, Bienvenu B, Marcelli C, Wendling D, Amoura Z, Dhote R, Lavigne C, Fior R, ... ... Mariette X, et al. Rheumatoid factor and disease activity are independent predictors of lymphoma in primary Sjögren's Syndrome. Arthritis & Rheumatology (Hoboken, N.J.). PMID 26606524 DOI: 10.1002/Art.39518  0.68
2015 Finckh A, Neto D, Iannone F, Loza E, Lie E, van Riel P, Hetland ML, Pavelka K, Gottenberg JE, Canhão H, Mariette X, Turesson C. The impact of patient heterogeneity and socioeconomic factors on abatacept retention in rheumatoid arthritis across nine European countries. Rmd Open. 1: e000040. PMID 26509062 DOI: 10.1136/Rmdopen-2014-000040  0.64
2015 Salmon JH, Cacoub P, Combe B, Sibilia J, Pallot-Prades B, Fain O, Cantagrel A, Dougados M, Andres E, Meyer O, Carli P, Pertuiset E, Pane I, Maurier F, Ravaud P, ... Mariette X, et al. Late-onset neutropenia after treatment with rituximab for rheumatoid arthritis and other autoimmune diseases: data from the AutoImmunity and Rituximab registry. Rmd Open. 1: e000034. PMID 26509060 DOI: 10.1136/Rmdopen-2014-000034  0.64
2015 Seror R, Bowman SJ, Brito-Zeron P, Theander E, Bootsma H, Tzioufas A, Gottenberg JE, Ramos-Casals M, Dörner T, Ravaud P, Vitali C, Mariette X, Asmussen K, Jacobsen S, Bartoloni E, et al. EULAR Sjögren's syndrome disease activity index (ESSDAI): a user guide. Rmd Open. 1: e000022. PMID 26509054 DOI: 10.1136/Rmdopen-2014-000022  0.76
2015 Crickx E, Machelart I, Lazaro E, Kahn JE, Cohen-Aubart F, Martin T, Mania A, Hatron PY, Hayem G, Blanchard-Delaunay C, de Moreuil C, Le Guenno G, Vandergheynst F, Maurier F, Crestani B, ... ... Mariette X, et al. Intravenous immunoglobulin as immunomodulating agent in ANCA-associated vasculitides: a French nationwide study of 92 patients. Arthritis & Rheumatology (Hoboken, N.J.). PMID 26473632 DOI: 10.1002/Art.39472  0.68
2015 Devauchelle-Pensec V, Gottenberg JE, Jousse-Joulin S, Berthelot JM, Perdriger A, Hachulla E, Hatron PY, Puechal X, Le Guern V, Sibilia J, Chiche L, Goeb V, Vittecoq O, Larroche C, Fauchais AL, ... ... Mariette X, et al. Which and How Many Patients Should Be Included in Randomised Controlled Trials to Demonstrate the Efficacy of Biologics in Primary Sjögren's Syndrome? Plos One. 10: e0133907. PMID 26368934 DOI: 10.1371/Journal.Pone.0133907  0.76
2015 Nocturne G, Tarn J, Boudaoud S, Locke J, Miceli-Richard C, Hachulla E, Dubost JJ, Bowman S, Gottenberg JE, Criswell LA, Lessard CJ, Sivils KL, Carapito R, Bahram S, Seror R, ... ... Mariette X, et al. Germline variation of TNFAIP3 in primary Sjögren's syndrome-associated lymphoma. Annals of the Rheumatic Diseases. PMID 26338037 DOI: 10.1136/Annrheumdis-2015-207731  0.68
2015 Seror R, Nocturne G, Lazure T, Hendel-Chavez H, Desmoulins F, Belkhir R, Ravaud P, Benbijja M, Poirier-Colame V, Taoufik Y, Mariette X. Low numbers of blood and salivary natural killer cells are associated with a better response to belimumab in primary Sjögren's syndrome: results of the BELISS study. Arthritis Research & Therapy. 17: 241. PMID 26336930 DOI: 10.1186/S13075-015-0750-Y  1
2015 Seror R, Mariette X. Reply: To PMID 25779552. Arthritis & Rheumatology (Hoboken, N.J.). 67: 3330. PMID 26315786 DOI: 10.1002/Art.39400  0.76
2015 Nocturne G, Pavy S, Boudaoud S, Seror R, Goupille P, Chanson P, van der Heijde D, van Gaalen F, Berenbaum F, Mariette X, Briot K, Feydy A, Claudepierre P, Dieudé P, Nithitham J, et al. Increase in Dickkopf-1 Serum Level in Recent Spondyloarthritis. Data from the DESIR Cohort. Plos One. 10: e0134974. PMID 26313358 DOI: 10.1371/Journal.Pone.0134974  0.68
2015 De Vita S, Quartuccio L, Seror R, Salvin S, Ravaud P, Fabris M, Nocturne G, Gandolfo S, Isola M, Mariette X. Efficacy and safety of belimumab given for 12 months in primary Sjögren's syndrome: the BELISS open-label phase II study. Rheumatology (Oxford, England). 54: 2249-56. PMID 26242856 DOI: 10.1093/Rheumatology/Kev257  1
2015 Danlos FX, Daoued F, Seror R, Mariette X. Orbital Myositis and Primary Sjögren Syndrome. The Journal of Rheumatology. 42: 1536-7. PMID 26233955 DOI: 10.3899/Jrheum.141318  0.76
2015 Ramos-Casals M, Brito-Zerón P, Seror R, Bootsma H, Bowman SJ, Dörner T, Gottenberg JE, Mariette X, Theander E, Bombardieri S, De Vita S, Mandl T, Ng WF, Kruize A, Tzioufas A, et al. Characterization of systemic disease in primary Sjögren's syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements. Rheumatology (Oxford, England). 54: 2230-8. PMID 26231345 DOI: 10.1093/Rheumatology/Kev200  0.68
2015 Vallet H, Riviere S, Sanna A, Deroux A, Moulis G, Addimanda O, Salvarani C, Lambert M, Bielefeld P, Seve P, Sibilia J, Pasquali J, Fraison J, Marie I, Perard L, ... ... Mariette X, et al. Efficacy of anti-TNF alpha in severe and/or refractory Behçet's disease: Multicenter study of 124 patients. Journal of Autoimmunity. PMID 26162757 DOI: 10.1016/J.Jaut.2015.06.005  0.68
2015 Gossec L, Danré A, Combe B, Le Loët X, Tebib J, Sibilia J, Mariette X, Dougados M. Improvement in patient-reported outcomes after rituximab in rheumatoid arthritis patients: An open-label assessment of 175 patients. Joint, Bone, Spine : Revue Du Rhumatisme. 82: 451-4. PMID 26162632 DOI: 10.1016/J.Jbspin.2015.02.007  0.6
2015 Jallouli M, Galicier L, Zahr N, Aumaître O, Francès C, Le Guern V, Lioté F, Smail A, Limal N, Perard L, Desmurs-Clavel H, Le Thi Huong D, Asli B, Kahn JE, Pourrat J, ... ... Mariette X, et al. Determinants of Hydroxychloroquine Blood Concentration Variations in Systemic Lupus Erythematosus. Arthritis & Rheumatology (Hoboken, N.J.). 67: 2176-84. PMID 25989906 DOI: 10.1002/Art.39194  0.68
2015 Rup B, Pallardy M, Sikkema D, Albert T, Allez M, Broet P, Carini C, Creeke P, Davidson J, De Vries N, Finco D, Fogdell-Hahn A, Havrdova E, Hincelin-Mery A, Holland MC, ... ... Mariette X, et al. Standardizing terms, definitions and concepts for describing and interpreting unwanted immunogenicity of biopharmaceuticals: Recommendations of the innovative medicines initiative ABIRISK consortium. Clinical and Experimental Immunology. PMID 25959571 DOI: 10.1111/Cei.12652  0.68
2015 Cornec D, Devauchelle-Pensec V, Mariette X, Jousse-Joulin S, Berthelot JM, Perdriger A, Puéchal X, Le Guern V, Sibilia J, Gottenberg JE, Chiche L, Hachulla E, Hatron PY, Goeb V, Hayem G, et al. Development of the Sjögren's Syndrome Responder Index, a data-driven composite endpoint for assessing treatment efficacy. Rheumatology (Oxford, England). 54: 1699-708. PMID 25957440 DOI: 10.1093/Rheumatology/Kev114  0.76
2015 Diogo D, Bastarache L, Liao KP, Graham RR, Fulton RS, Greenberg JD, Eyre S, Bowes J, Cui J, Lee A, Pappas DA, Kremer JM, Barton A, Coenen MJ, Franke B, ... ... Mariette X, et al. TYK2 protein-coding variants protect against rheumatoid arthritis and autoimmunity, with no evidence of major pleiotropic effects on non-autoimmune complex traits. Plos One. 10: e0122271. PMID 25849893 DOI: 10.1371/Journal.Pone.0122271  0.68
2015 Miceli-Richard C, Taylor KE, Nititham J, Seror R, Nocturne G, Boudaoud S, Dieude P, Constantin A, Devauchelle-Pensec V, Tobón GJ, Mariette X, Criswell LA. Genetic contribution of DKK-1 polymorphisms to RA structural severity and DKK-1 level of expression. Annals of the Rheumatic Diseases. 74: 1480-1. PMID 25805736 DOI: 10.1136/Annrheumdis-2014-206530  0.68
2015 Seror R, Le Gall-David S, Bonnaure-Mallet M, Schaeverbeke T, Cantagrel A, Minet J, Gottenberg JE, Chanson P, Ravaud P, Mariette X. Association of Anti-Porphyromonas gingivalis Antibody Titers With Nonsmoking Status in Early Rheumatoid Arthritis: Results From the Prospective French Cohort of Patients With Early Rheumatoid Arthritis. Arthritis & Rheumatology (Hoboken, N.J.). 67: 1729-37. PMID 25779552 DOI: 10.1002/Art.39118  0.76
2015 Baillet A, Gossec L, Paternotte S, Etcheto A, Combe B, Meyer O, Mariette X, Gottenberg JE, Dougados M. Evaluation of serum interleukin-6 level as a surrogate marker of synovial inflammation and as a factor of structural progression in early rheumatoid arthritis: results from a French national multicenter cohort. Arthritis Care & Research. 67: 905-12. PMID 25384758 DOI: 10.1002/Acr.22513  0.64
2015 Nocturne G, Mariette X. Sjögren Syndrome-associated lymphomas: an update on pathogenesis and management. British Journal of Haematology. 168: 317-27. PMID 25316606 DOI: 10.1111/Bjh.13192  1
2015 Kottyan LC, Zoller EE, Bene J, Lu X, Kelly JA, Rupert AM, Lessard CJ, Vaughn SE, Marion M, Weirauch MT, Namjou B, Adler A, Rasmussen A, Glenn S, Montgomery CG, ... ... Mariette X, et al. The IRF5-TNPO3 association with systemic lupus erythematosus has two components that other autoimmune disorders variably share. Human Molecular Genetics. 24: 582-96. PMID 25205108 DOI: 10.1093/Hmg/Ddu455  0.68
2015 Dougados M, Soubrier M, Perrodeau E, Gossec L, Fayet F, Gilson M, Cerato MH, Pouplin S, Flipo RM, Chabrefy L, Mouterde G, Euller-Ziegler L, Schaeverbeke T, Fautrel B, Saraux A, ... ... Mariette X, et al. Impact of a nurse-led programme on comorbidity management and impact of a patient self-assessment of disease activity on the management of rheumatoid arthritis: results of a prospective, multicentre, randomised, controlled trial (COMEDRA). Annals of the Rheumatic Diseases. 74: 1725-33. PMID 24872377 DOI: 10.1136/Annrheumdis-2013-204733  0.6
2015 Seror R, Theander E, Brun JG, Ramos-Casals M, Valim V, Dörner T, Bootsma H, Tzioufas A, Solans-Laqué R, Mandl T, Gottenberg JE, Hachulla E, Sivils KL, Ng WF, Fauchais AL, ... ... Mariette X, et al. Validation of EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient indexes (ESSPRI). Annals of the Rheumatic Diseases. 74: 859-66. PMID 24442883 DOI: 10.1136/Annrheumdis-2013-204615  0.68
2015 Mariette X, Seror R, Quartuccio L, Baron G, Salvin S, Fabris M, Desmoulins F, Nocturne G, Ravaud P, De Vita S. Efficacy and safety of belimumab in primary Sjögren's syndrome: results of the BELISS open-label phase II study. Annals of the Rheumatic Diseases. 74: 526-31. PMID 24347569 DOI: 10.1136/Annrheumdis-2013-203991  1
2015 Vita SD, Quartuccio L, Seror R, Salvin S, Ravaud P, Fabris M, Nocturne G, Gandolfo S, Isola M, Mariette X. THU0392 Efficacy and Safety of Belimumab Given for 12 Months in Primary sjögren's Syndrome: The Beliss Open-Label Phase II Study Annals of the Rheumatic Diseases. 74: 338-339. DOI: 10.1136/Annrheumdis-2015-Eular.3101  1
2015 Mercer L, Askling J, Raaschou P, Dixon W, Dreyer L, Hetland M, Mellemkjær L, Strangfeld A, Zink A, Iannone F, Finckh A, Zavada J, Canhao H, Martins F, Mariette X, et al. 099. Risk of Developing a First Invasive Melanoma in Rheumatoid Arthritis Patients Treated with Biologics: Results of a Collaborative Project of 11 European Biologics Registers Rheumatology. 54. DOI: 10.1093/Rheumatology/Kev088.099  0.52
2015 Mercer L, Mariette X, Dixon W, Baecklund E, Hellgren K, Dreyer L, Hetland M, Mellemkjær L, Hyrich K, Strangfeld A, Zink A, Canhao H, Martins F, Hernández V, Tubach F, et al. O07. First Results of a European Registries Collaborative Project to Describe the Spectrum of Lymphomas Across Different Drug Treatment Groups in Rheumatoid Arthritis Rheumatology. 54: 25-25. DOI: 10.1093/Rheumatology/Kev080.001  0.52
2015 Jallouli M, Galicier L, Zahr N, Aumaître O, Francès C, Le Guern V, Lioté F, Smail A, Limal N, Perard L, Desmurs-Clavel H, Le Thi Huong D, Asli B, Kahn JE, Pourrat J, ... ... Mariette X, et al. Determinants of hydroxychloroquine blood concentration variations in systemic lupus erythematosus Arthritis and Rheumatology. 67: 2176-2184. DOI: 10.1002/art.39194  0.68
2014 Maldini C, Seror R, Fain O, Dhote R, Amoura Z, De Bandt M, Delassus JL, Falgarone G, Guillevin L, Le Guern V, Lhote F, Meyer O, Ramanoelina J, Sacré K, Uzunhan Y, ... ... Mariette X, et al. Error in the Abstract in the Article by Maldini et al (Arthritis Care Res [Hoboken], March 2014). Arthritis Care & Research. 66: 794. PMID 26205965 DOI: 10.1002/Acr.22347  0.76
2014 Durez P, Vandepapeliere P, Miranda P, Toncheva A, Berman A, Kehler T, Mociran E, Fautrel B, Mariette X, Dhellin O, Fanget B, Ouary S, Grouard-Vogel G, Boissier MC. Therapeutic vaccination with TNF-Kinoid in TNF antagonist-resistant rheumatoid arthritis: a phase II randomized, controlled clinical trial. Plos One. 9: e113465. PMID 25517733 DOI: 10.1371/Journal.Pone.0113465  0.68
2014 Seror R, Bootsma H, Saraux A, Bowman SJ, Theander E, Brun JG, Baron G, Le Guern V, Devauchelle-Pensec V, Ramos-Casals M, Valim V, Dörner T, Tzioufas A, Gottenberg JE, Solans Laqué R, ... ... Mariette X, et al. Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI). Annals of the Rheumatic Diseases. PMID 25480887 DOI: 10.1136/Annrheumdis-2014-206008  0.76
2014 Payet S, Soubrier M, Perrodeau E, Bardin T, Cantagrel A, Combe B, Dougados M, Flipo RM, Le Loët X, Shaeverbeke T, Ravaud P, Gottenberg JE, Mariette X. Efficacy and safety of rituximab in elderly patients with rheumatoid arthritis enrolled in a French Society of Rheumatology registry. Arthritis Care & Research. 66: 1289-95. PMID 25299001 DOI: 10.1002/Acr.22314  0.64
2014 Gottenberg JE, Ravaud P, Puéchal X, Le Guern V, Sibilia J, Goeb V, Larroche C, Dubost JJ, Rist S, Saraux A, Devauchelle-Pensec V, Morel J, Hayem G, Hatron P, Perdriger A, ... ... Mariette X, et al. Effects of hydroxychloroquine on symptomatic improvement in primary Sjögren syndrome: the JOQUER randomized clinical trial. Jama. 312: 249-58. PMID 25027140 DOI: 10.1001/Jama.2014.7682  0.76
2014 Couderc M, Gottenberg JE, Mariette X, Pereira B, Bardin T, Cantagrel A, Combe B, Dougados M, Flipo RM, Le Loët X, Shaeverbeke T, Ravaud P, Soubrier M. Influence of gender on response to rituximab in patients with rheumatoid arthritis: results from the Autoimmunity and Rituximab registry. Rheumatology (Oxford, England). 53: 1788-93. PMID 24821852 DOI: 10.1093/Rheumatology/Keu176  0.64
2014 Chevreul K, Haour G, Lucier S, Harvard S, Laroche ML, Mariette X, Saraux A, Durand-Zaleski I, Guillemin F, Fautrel B. Evolution of direct costs in the first years of rheumatoid arthritis: impact of early versus late biologic initiation--an economic analysis based on the ESPOIR cohort. Plos One. 9: e97077. PMID 24811196 DOI: 10.1371/Journal.Pone.0097077  0.68
2014 Sellam J, Marion-Thore S, Dumont F, Jacques S, Garchon HJ, Rouanet S, Taoufik Y, Hendel-Chavez H, Sibilia J, Tebib J, Le Loët X, Combe B, Dougados M, Mariette X, Chiocchia G. Use of whole-blood transcriptomic profiling to highlight several pathophysiologic pathways associated with response to rituximab in patients with rheumatoid arthritis: data from a randomized, controlled, open-label trial. Arthritis & Rheumatology (Hoboken, N.J.). 66: 2015-25. PMID 24756903 DOI: 10.1002/Art.38671  0.68
2014 van Vollenhoven RF, Mosca M, Bertsias G, Isenberg D, Kuhn A, Lerstrøm K, Aringer M, Bootsma H, Boumpas D, Bruce IN, Cervera R, Clarke A, Costedoat-Chalumeau N, Czirják L, Derksen R, ... ... Mariette X, et al. Treat-to-target in systemic lupus erythematosus: recommendations from an international task force. Annals of the Rheumatic Diseases. 73: 958-67. PMID 24739325 DOI: 10.1136/Annrheumdis-2013-205139  0.68
2014 Devauchelle-Pensec V, Mariette X, Jousse-Joulin S, Berthelot JM, Perdriger A, Puéchal X, Le Guern V, Sibilia J, Gottenberg JE, Chiche L, Hachulla E, Hatron PY, Goeb V, Hayem G, Morel J, et al. Treatment of primary Sjögren syndrome with rituximab: a randomized trial. Annals of Internal Medicine. 160: 233-42. PMID 24727841 DOI: 10.7326/M13-1085  0.64
2014 Frazier-Mironer A, Dougados M, Mariette X, Cantagrel A, Deschamps V, Flipo RM, Logeart I, Schaeverbeke T, Sibilia J, Le Loët X, Combe B. Retention rates of adalimumab, etanercept and infliximab as first and second-line biotherapy in patients with rheumatoid arthritis in daily practice. Joint, Bone, Spine : Revue Du Rhumatisme. 81: 352-9. PMID 24721422 DOI: 10.1016/J.Jbspin.2014.02.014  0.6
2014 Guillaume-Czitrom S, Bachelez H, Berthelot J, Bouhnik Y, Bruckert E, Claudepierre P, Constantin A, Bandt Md, Fautrel B, Gaudin P, Goëb V, Gossec L, Gottenberg J, Goupille P, Hachulla E, ... ... Mariette X, et al. Biologic targeted therapies in pediatric rheumatology. Joint Bone Spine. 81: 2-48. PMID 24661916 DOI: 10.1016/S1297-319X(14)70020-X  0.68
2014 Okada Y, Diogo D, Greenberg JD, Mouassess F, Achkar WA, Fulton RS, Denny JC, Gupta N, Mirel D, Gabriel S, Li G, Kremer JM, Pappas DA, Carroll RJ, Eyler AE, ... ... Mariette X, et al. Integration of sequence data from a Consanguineous family with genetic data from an outbred population identifies PLB1 as a candidate rheumatoid arthritis risk gene. Plos One. 9: e87645. PMID 24520335 DOI: 10.1371/Journal.Pone.0087645  0.68
2014 Seror R, Theander E, Bootsma H, Bowman SJ, Tzioufas A, Gottenberg JE, Ramos-Casals M, Dörner T, Ravaud P, Mariette X, Vitali C. Outcome measures for primary Sjögren's syndrome: a comprehensive review. Journal of Autoimmunity. 51: 51-6. PMID 24411404 DOI: 10.1016/J.Jaut.2013.12.010  0.76
2014 Gong YZ, Nititham J, Taylor K, Miceli-Richard C, Sordet C, Wachsmann D, Bahram S, Georgel P, Criswell LA, Sibilia J, Mariette X, Alsaleh G, Gottenberg JE. Differentiation of follicular helper T cells by salivary gland epithelial cells in primary Sjögren's syndrome. Journal of Autoimmunity. 51: 57-66. PMID 24411167 DOI: 10.1016/J.Jaut.2013.11.003  0.84
2014 Okada Y, Wu D, Trynka G, Raj T, Terao C, Ikari K, Kochi Y, Ohmura K, Suzuki A, Yoshida S, Graham RR, Manoharan A, Ortmann W, Bhangale T, Denny JC, ... ... Mariette X, et al. Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature. 506: 376-81. PMID 24390342 DOI: 10.1038/Nature12873  0.68
2014 Roescher N, Vosters JL, Alsaleh G, Dreyfus P, Jacques S, Chiocchia G, Sibilia J, Tak PP, Chiorini JA, Mariette X, Gottenberg JE. Targeting the splicing of mRNA in autoimmune diseases: BAFF inhibition in Sjögren's syndrome as a proof of concept. Molecular Therapy : the Journal of the American Society of Gene Therapy. 22: 821-7. PMID 24304965 DOI: 10.1038/Mt.2013.275  0.68
2014 Smolen JS, Landewé R, Breedveld FC, Buch M, Burmester G, Dougados M, Emery P, Gaujoux-Viala C, Gossec L, Nam J, Ramiro S, Winthrop K, de Wit M, Aletaha D, Betteridge N, ... ... Mariette X, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Annals of the Rheumatic Diseases. 73: 492-509. PMID 24161836 DOI: 10.1136/annrheumdis-2013-204573  0.68
2014 Maldini C, Seror R, Fain O, Dhote R, Amoura Z, De Bandt M, Delassus JL, Falgarone G, Guillevin L, Le Guern V, Lhote F, Meyer O, Ramanoelina J, Sacré K, Uzunhan Y, ... ... Mariette X, et al. Epidemiology of primary Sjögren's syndrome in a French multiracial/multiethnic area. Arthritis Care & Research. 66: 454-63. PMID 23983119 DOI: 10.1002/Acr.22115  0.68
2014 Seror R, Baron G, Hachulla E, Debandt M, Larroche C, Puéchal X, Maurier F, de Wazieres B, Quéméneur T, Ravaud P, Mariette X. Adalimumab for steroid sparing in patients with giant-cell arteritis: results of a multicentre randomised controlled trial. Annals of the Rheumatic Diseases. 73: 2074-81. PMID 23897775 DOI: 10.1136/Annrheumdis-2013-203586  0.76
2014 Ebbo M, Grados A, Guedj E, Gobert D, Colavolpe C, Zaidan M, Masseau A, Bernard F, Berthelot JM, Morel N, Lifermann F, Palat S, Haroche J, Mariette X, Godeau B, et al. Usefulness of 2-[18F]-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography for staging and evaluation of treatment response in IgG4-related disease: a retrospective multicenter study. Arthritis Care & Research. 66: 86-96. PMID 23836437 DOI: 10.1002/Acr.22058  0.68
2014 Mariette X, Rouanet S, Sibilia J, Combe B, Le Loët X, Tebib J, Jourdan R, Dougados M. Evaluation of low-dose rituximab for the retreatment of patients with active rheumatoid arthritis: a non-inferiority randomised controlled trial. Annals of the Rheumatic Diseases. 73: 1508-14. PMID 23723317 DOI: 10.1136/Annrheumdis-2013-203480  0.6
2013 Nocturne G, Boudaoud S, Miceli-Richard C, Viengchareun S, Lazure T, Nititham J, Taylor KE, Ma A, Busato F, Melki J, Lessard CJ, Sivils KL, Dubost JJ, Hachulla E, Gottenberg JE, ... ... Mariette X, et al. Germline and somatic genetic variations of TNFAIP3 in lymphoma complicating primary Sjogren's syndrome. Blood. 122: 4068-76. PMID 24159176 DOI: 10.1182/Blood-2013-05-503383  0.68
2013 Lessard CJ, Li H, Adrianto I, Ice JA, Rasmussen A, Grundahl KM, Kelly JA, Dozmorov MG, Miceli-Richard C, Bowman S, Lester S, Eriksson P, Eloranta ML, Brun JG, Gøransson LG, ... ... Mariette X, et al. Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjögren's syndrome. Nature Genetics. 45: 1284-92. PMID 24097067 DOI: 10.1038/Ng.2792  0.68
2013 Lessard CJ, Li H, Adrianto I, Ice JA, Dozmorov MG, Jonsson R, Rischmueller M, Nordmark G, Mariette X, Miceli-Richard C, Wahren-Herlenius M, Witte T, Brennan MT, Omdal R, Rönnblom L, et al. Complex Functional Effects Within The HLA Contribute To Sjogren's Syndrome Pathogenesis and May Influence Both Transcriptional Regulation and Peptide Binding Arthritis & Rheumatism. 65. PMID 24085684 DOI: 10.1002/Art.38216  0.84
2013 Tobón GJ, Saraux A, Gottenberg JE, Quartuccio L, Fabris M, Seror R, Devauchelle-Pensec V, Morel J, Rist S, Mariette X, De Vita S, Youinou P, Pers JO. Role of Fms-like tyrosine kinase 3 ligand as a potential biologic marker of lymphoma in primary Sjögren's syndrome. Arthritis and Rheumatism. 65: 3218-27. PMID 23982978 DOI: 10.1002/Art.38129  0.76
2013 Combe B, Rincheval N, Benessiano J, Berenbaum F, Cantagrel A, Daurès JP, Dougados M, Fardellone P, Fautrel B, Flipo RM, Goupille P, Guillemin F, Le Loët X, Logeart I, Mariette X, et al. Five-year favorable outcome of patients with early rheumatoid arthritis in the 2000s: data from the ESPOIR cohort. The Journal of Rheumatology. 40: 1650-7. PMID 23950185 DOI: 10.3899/Jrheum.121515  0.6
2013 Loulergue P, Tubach F, Salmon D, Dellamonica P, Taillan B, Thorel JB, Marteau P, Bressot C, Ravaud P, Mariette X, Lortholary O. Bacteremia in patients receiving TNF-alpha antagonists - A prospective multicenter study Journal of Infection. 67: 524-528. PMID 23921318 DOI: 10.1016/J.Jinf.2013.07.027  0.68
2013 Rusakiewicz S, Nocturne G, Lazure T, Semeraro M, Flament C, Caillat-Zucman S, Sène D, Delahaye N, Vivier E, Chaba K, Poirier-Colame V, Nordmark G, Eloranta ML, Eriksson P, Theander E, ... ... Mariette X, et al. NCR3/NKp30 contributes to pathogenesis in primary Sjogren's syndrome. Science Translational Medicine. 5: 195ra96. PMID 23884468 DOI: 10.1126/Scitranslmed.3005727  0.68
2013 Tobón G, Saraux A, Lukas C, Gandjbakhch F, Gottenberg JE, Mariette X, Combe B, Devauchelle-Pensec V. First-year radiographic progression as a predictor of further progression in early arthritis: results of a large national French cohort. Arthritis Care & Research. 65: 1907-15. PMID 23861163 DOI: 10.1002/Acr.22078  0.64
2013 Nocturne G, Mariette X. Advances in understanding the pathogenesis of primary Sjögren's syndrome. Nature Reviews. Rheumatology. 9: 544-56. PMID 23857130 DOI: 10.1038/Nrrheum.2013.110  1
2013 Godot S, Gottenberg JE, Paternotte S, Pane I, Combe B, Sibilia J, Flipo RM, Schaeverbeke T, Ravaud P, Toussirot E, Berenbaum F, Mariette X, Wendling D, Sellam J. Safety of surgery after rituximab therapy in 133 patients with rheumatoid arthritis: Data from the autoimmunity and rituximab registry Arthritis Care and Research. 65: 1874-1879. PMID 23754822 DOI: 10.1002/Acr.22056  0.68
2013 Lanternier F, Tubach F, Ravaud P, Salmon D, Dellamonica P, Bretagne S, Couret M, Bouvard B, Debandt M, Gueit I, Gendre JP, Leone J, Nicolas N, Che D, Mariette X, et al. Incidence and risk factors of legionella pneumophila pneumonia during anti-tumor necrosis factor therapy: A prospective French study Chest. 144: 990-998. PMID 23744173 DOI: 10.1378/Chest.12-2820  0.68
2013 Sellam J, Rouanet S, Hendel-Chavez H, Miceli-Richard C, Combe B, Sibilia J, Le Loët X, Tebib J, Jourdan R, Dougados M, Taoufik Y, Mariette X. CCL19, a B cell chemokine, is related to the decrease of blood memory B cells and predicts the clinical response to rituximab in patients with rheumatoid arthritis. Arthritis and Rheumatism. 65: 2253-61. PMID 23740460 DOI: 10.1002/Art.38023  0.84
2013 Gottenberg JE, Seror R, Miceli-Richard C, Benessiano J, Devauchelle-Pensec V, Dieude P, Dubost JJ, Fauchais AL, Goeb V, Hachulla E, Hatron PY, Larroche C, Le Guern V, Morel J, Perdriger A, ... ... Mariette X, et al. Serum levels of beta2-microglobulin and free light chains of immunoglobulins are associated with systemic disease activity in primary Sjögren's syndrome. Data at enrollment in the prospective ASSESS cohort. Plos One. 8: e59868. PMID 23717383 DOI: 10.1371/Journal.Pone.0059868  1
2013 Plenge RM, Greenberg JD, Mangravite LM, Derry JM, Stahl EA, Coenen MJ, Barton A, Padyukov L, Klareskog L, Gregersen PK, Mariette X, Moreland LW, Bridges SL, de Vries N, Huizinga TW, et al. Crowdsourcing genetic prediction of clinical utility in the Rheumatoid Arthritis Responder Challenge. Nature Genetics. 45: 468-9. PMID 23619782 DOI: 10.1038/Ng.2623  0.68
2013 Cui J, Stahl EA, Saevarsdottir S, Miceli C, Diogo D, Trynka G, Raj T, Mirkov MU, Canhao H, Ikari K, Terao C, Okada Y, Wedrén S, Askling J, Yamanaka H, ... ... Mariette X, et al. Genome-wide association study and gene expression analysis identifies CD84 as a predictor of response to etanercept therapy in rheumatoid arthritis. Plos Genetics. 9: e1003394. PMID 23555300 DOI: 10.1371/Journal.Pgen.1003394  0.68
2013 Saraux A, Tobón GJ, Benhamou M, Devauchelle-Pensec V, Dougados M, Mariette X, Berenbaum F, Chiocchia G, Rat AC, Schaeverbeke T, Rincheval N, Meyer O, Fautrel B, Combe B. Potential classification criteria for rheumatoid arthritis after two years: results from a French multicenter cohort. Arthritis Care & Research. 65: 1227-34. PMID 23401491 DOI: 10.1002/Acr.21982  0.32
2013 Seror R, Richez C, Sordet C, Rist S, Gossec L, Direz G, Houvenagel E, Berthelot JM, Pagnoux C, Dernis E, Melac-Ducamp S, Bouvard B, Asquier C, Martin A, Puechal X, ... Mariette X, et al. Pattern of demyelination occurring during anti-TNF-α therapy: a French national survey. Rheumatology (Oxford, England). 52: 868-74. PMID 23287362 DOI: 10.1093/Rheumatology/Kes375  0.76
2013 Ruyssen-Witrand A, Rouanet S, Combe B, Dougados M, Le Loët X, Sibilia J, Tebib J, Mariette X, Constantin A. Association between -871C>T promoter polymorphism in the B-cell activating factor gene and the response to rituximab in rheumatoid arthritis patients. Rheumatology (Oxford, England). 52: 636-41. PMID 23264555 DOI: 10.1093/rheumatology/kes344  0.6
2013 Vitali C, Bootsma H, Bowman SJ, Dorner T, Gottenberg JE, Mariette X, Ramos-Casals M, Ravaud P, Seror R, Theander E, Tzioufas AG. Classification criteria for Sjogren's syndrome: we actually need to definitively resolve the long debate on the issue. Annals of the Rheumatic Diseases. 72: 476-8. PMID 23264355 DOI: 10.1136/Annrheumdis-2012-202565  0.76
2013 Gottenberg JE, Cinquetti G, Larroche C, Combe B, Hachulla E, Meyer O, Pertuiset E, Kaplanski G, Chiche L, Berthelot JM, Gombert B, Goupille P, Marcelli C, Feuillet S, Leone J, ... ... Mariette X, et al. Efficacy of rituximab in systemic manifestations of primary Sjogren's syndrome: results in 78 patients of the AutoImmune and Rituximab registry. Annals of the Rheumatic Diseases. 72: 1026-31. PMID 23264337 DOI: 10.1136/Annrheumdis-2012-202293  0.64
2013 UmiÄ‹eviÄ‹ Mirkov M, Cui J, Vermeulen SH, Stahl EA, Toonen EJ, Makkinje RR, Lee AT, Huizinga TW, Allaart R, Barton A, Mariette X, Miceli CR, Criswell LA, Tak PP, de Vries N, et al. Genome-wide association analysis of anti-TNF drug response in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases. 72: 1375-81. PMID 23233654 DOI: 10.1136/Annrheumdis-2012-202405  0.68
2013 Jachiet M, Lependu C, Fragny D, Mariette X, Lepajolec C, Seror R. Severe deafness associated with Crohn's disease and spondylarthropathy: successful treatment with anti-TNF. Rheumatology (Oxford, England). 52: 1145-7. PMID 23221328 DOI: 10.1093/Rheumatology/Kes346  0.76
2013 Terrier B, Carrat F, Krastinova E, Marie I, Launay D, Lacraz A, Belenotti P, De Saint Martin L, Quemeneur T, Huart A, Bonnet F, Guenno GL, Kahn JE, Hinschberger O, Rullier P, ... ... Mariette X, et al. Prognostic factors of survival in patients with non-infectious mixed cryoglobulinaemia vasculitis: Data from 242 cases included in the CryoVas survey Annals of the Rheumatic Diseases. 72: 374-380. PMID 22586172 DOI: 10.1136/Annrheumdis-2012-201405  0.68
2013 Combe B, Rincheval N, Benessiano J, Berenbaum F, Cantagrel A, Daures J-, Dougados M, Fardellone P, Fautrel B, Flipo R-, Goupille P, Guillemin F, Loet XL, Logeart I, Mariette X, et al. SAT0044 Five-Year Favourable Outcome of Patients with Early Rheumatoid Arthritis in the 2000S: Data from the Espoir Cohort Annals of the Rheumatic Diseases. 72. DOI: 10.1136/Annrheumdis-2013-Eular.1770  0.6
2013 Seror R, Mariette X, Bowman S, Baron G, Gottenberg JE, Boostma H, Theander E, Tzioufas A, Vitali C, Ravaud P. Incorrect Spelling of Author Name in the Article by Seror et al (Arthritis Care Res [Hoboken], April 2010) Arthritis Care and Research. 65: 1392-1392. DOI: 10.1002/Acr.22080  0.76
2012 Gestermann N, Koutero M, Belkhir R, Tost J, Mariette X, Miceli-Richard C. Methylation profile of the promoter region of IRF5 in primary Sjögren's syndrome. European Cytokine Network. 23: 166-72. PMID 23302156 DOI: 10.1684/Ecn.2012.0316  0.84
2012 Gottenberg JE, Ravaud P, Cantagrel A, Combe B, Flipo RM, Schaeverbeke T, Houvenagel E, Gaudin P, Loeuille D, Rist S, Dougados M, Sibilia J, Le Loët X, Marcelli C, Bardin T, ... ... Mariette X, et al. Positivity for anti-cyclic citrullinated peptide is associated with a better response to abatacept: Data from the 'Orencia and Rheumatoid Arthritis' registry Annals of the Rheumatic Diseases. 71: 1815-1819. PMID 22615458 DOI: 10.1136/Annrheumdis-2011-201109  0.68
2012 Pham T, Bachelez H, Berthelot JM, Blacher J, Claudepierre P, Constantin A, Fautrel B, Gaujoux-Viala C, Goëb V, Gossec L, Goupille P, Guillaume-Czitrom S, Hachulla E, Lequerré T, Marolleau JP, ... ... Mariette X, et al. Abatacept therapy and safety management. Joint, Bone, Spine : Revue Du Rhumatisme. 79: 3-84. PMID 22541956 DOI: 10.1016/S1297-319X(12)70011-8  0.6
2012 Gottenberg JE, Dayer JM, Lukas C, Ducot B, Chiocchia G, Cantagrel A, Saraux A, Roux-Lombard P, Mariette X. Serum IL-6 and IL-21 are associated with markers of B cell activation and structural progression in early rheumatoid arthritis: results from the ESPOIR cohort. Annals of the Rheumatic Diseases. 71: 1243-8. PMID 22532637 DOI: 10.1136/Annrheumdis-2011-200975  0.64
2012 Glace B, Gottenberg JE, Mariette X, Philippe R, Pereira B, Lequerré T, Berthelot JM, Dougados M, Toussirot E, Pham T, Allanore Y, Loeuille D, Euller-Ziegler L, Soubrier M. Efficacy of rituximab in the treatment of pulmonary rheumatoid nodules: findings in 10 patients from the French AutoImmunity and Rituximab/Rheumatoid Arthritis registry (AIR/PR registry). Annals of the Rheumatic Diseases. 71: 1429-31. PMID 22504557 DOI: 10.1136/Annrheumdis-2011-200915  0.64
2012 Seror R, Bootsma H, Bowman SJ, Dörner T, Gottenberg JE, Mariette X, Ramos-Casals M, Ravaud P, Theander E, Tzioufas A, Vitali C. Outcome measures for primary Sjögren's syndrome. Journal of Autoimmunity. 39: 97-102. PMID 22365784 DOI: 10.1016/J.Jaut.2012.01.013  0.76
2012 Mekinian A, Ravaud P, Larroche C, Hachulla E, Gombert B, Blanchard-Delaunay C, Cantagrel A, Fain O, Sibilia J, Gottenberg JE, Mariette X. Rituximab in central nervous system manifestations of patients with primary Sjögren's syndrome: results from the AIR registry. Clinical and Experimental Rheumatology. 30: 208-12. PMID 22341206  0.64
2012 Boyer JF, Bongard V, Cantagrel A, Jamard B, Gottenberg JE, Mariette X, Davignon JL, Ferrières J, Ruidavets JB, Dallongeville J, Arveiler D, Cambon-Thomsen A, Constantin A. Link between traditional cardiovascular risk factors and inflammation in patients with early arthritis: results from a French multicenter cohort. Arthritis Care & Research. 64: 872-80. PMID 22275176 DOI: 10.1002/Acr.21623  0.64
2012 Mariette X, Baron G, Tubach F, Lioté F, Combe B, Miceli-Richard C, Flipo RM, Goupille P, Allez M, Salmon D, Emilie D, Carcelain G, Ravaud P. Influence of replacing tuberculin skin test with ex vivo interferon γ release assays on decision to administer prophylactic antituberculosis antibiotics before anti-TNF therapy. Annals of the Rheumatic Diseases. 71: 1783-90. PMID 22258485 DOI: 10.1136/Annrheumdis-2011-200408  0.84
2012 Gottenberg JE, Mariette X. Primary Sjögren's syndrome: time for prospective cohorts. Current Pharmaceutical Biotechnology. 13: 2022-5. PMID 22208655 DOI: 10.2174/138920112802273128  0.64
2012 Serac G, Tubach F, Mariette X, Salmon-Céron D, Ravaud P, Lioté F, Laharie D, Ziza JM, Marguerie L, Bonnet C, Falgarone G, Nicolas N, Lortholary O, Chosidow O. Risk of herpes zoster in patients receiving anti-TNF-α in the prospective French RATIO registry. The Journal of Investigative Dermatology. 132: 726-9. PMID 22113472 DOI: 10.1038/Jid.2011.383  0.44
2012 Mekinian A, Ravaud P, Hatron PY, Larroche C, Leone J, Gombert B, Hamidou M, Cantagrel A, Marcelli C, Rist S, Breban M, Launay D, Fain O, Gottenberg JE, Mariette X. Efficacy of rituximab in primary Sjogren's syndrome with peripheral nervous system involvement: results from the AIR registry. Annals of the Rheumatic Diseases. 71: 84-7. PMID 21926185 DOI: 10.1136/Annrheumdis-2011-200086  0.64
2011 Sellam J, Rouanet S, Hendel-Chavez H, Abbed K, Sibilia J, Tebib J, Le Loët X, Combe B, Dougados M, Mariette X, Taoufik Y. Blood memory B cells are disturbed and predict the response to rituximab in patients with rheumatoid arthritis. Arthritis and Rheumatism. 63: 3692-701. PMID 22127692 DOI: 10.1002/Art.30599  0.68
2011 Couderc M, Gottenberg JE, Mariette X, Hachulla E, Sibilia J, Fain O, Hot A, Dougados M, Euller-Ziegler L, Bourgeois P, Larroche C, Tournadre A, Amoura Z, Mazières B, Arlet P, et al. Efficacy and safety of rituximab in the treatment of refractory inflammatory myopathies in adults: results from the AIR registry. Rheumatology (Oxford, England). 50: 2283-9. PMID 22019807 DOI: 10.1093/Rheumatology/Ker305  0.64
2011 Mekinian A, Tamouza R, Pavy S, Gestermann N, Ittah M, Mariette X, Miceli-Richard C. Functional study of TNF-α promoter polymorphisms: literature review and meta-analysis. European Cytokine Network. 22: 88-102. PMID 21768061 DOI: 10.1684/Ecn.2011.0285  0.84
2011 Pham T, Bachelez H, Berthelot JM, Blacher J, Bouhnik Y, Claudepierre P, Constantin A, Fautrel B, Gaudin P, Goëb V, Gossec L, Goupille P, Guillaume-Czitrom S, Hachulla E, Huet I, ... ... Mariette X, et al. TNF alpha antagonist therapy and safety monitoring. Joint, Bone, Spine : Revue Du Rhumatisme. 78: 15-185. PMID 21703545 DOI: 10.1016/S1297-319X(11)70001-X  0.68
2011 Payet J, Seror R, Hanss J, Clerc D, Miceli C, Pavy S, Le Pajolec C, Mariette X. Cervical syphilitic spondylodiscitis associated with neurosyphilis. Rheumatology (Oxford, England). 50: 1723-5. PMID 21622520 DOI: 10.1093/Rheumatology/Ker185  0.76
2011 Rist S, Sellam J, Hachulla E, Sordet C, Puéchal X, Hatron PY, Benhamou CL, Sibilia J, Mariette X. Experience of intravenous immunoglobulin therapy in neuropathy associated with primary Sjögren's syndrome: a national multicentric retrospective study. Arthritis Care & Research. 63: 1339-44. PMID 21584943 DOI: 10.1002/Acr.20495  0.68
2011 Vallet H, Houitte R, Azria A, Mariette X. Cytomegalovirus colitis and hypo-IgG after rituximab therapy for rheumatoid arthritis. The Journal of Rheumatology. 38: 965-6. PMID 21532065 DOI: 10.3899/Jrheum.100818  0.44
2011 Buch MH, Smolen JS, Betteridge N, Breedveld FC, Burmester G, Dörner T, Ferraccioli G, Gottenberg JE, Isaacs J, Kvien TK, Mariette X, Martin-Mola E, Pavelka K, Tak PP, van der Heijde D, et al. Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases. 70: 909-20. PMID 21378402 DOI: 10.1136/Ard.2010.144998  0.64
2011 Seror R, Ravaud P, Mariette X, Bootsma H, Theander E, Hansen A, Ramos-Casals M, Dörner T, Bombardieri S, Hachulla E, Brun JG, Kruize AA, Praprotnik S, Tomsic M, Gottenberg JE, et al. EULAR Sjogren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjogren's syndrome. Annals of the Rheumatic Diseases. 70: 968-72. PMID 21345815 DOI: 10.1136/Ard.2010.143743  0.76
2011 Sellam J, Hendel-Chavez H, Rouanet S, Abbed K, Combe B, Le Loët X, Tebib J, Sibilia J, Taoufik Y, Dougados M, Mariette X. B cell activation biomarkers as predictive factors for the response to rituximab in rheumatoid arthritis: a six-month, national, multicenter, open-label study. Arthritis and Rheumatism. 63: 933-8. PMID 21225699 DOI: 10.1002/Art.30233  0.68
2011 Mariette X, Gottenberg JE, Ravaud P, Combe B. Registries in rheumatoid arthritis and autoimmune diseases: data from the French registries. Rheumatology (Oxford, England). 50: 222-9. PMID 21148156 DOI: 10.1093/Rheumatology/Keq368  0.64
2011 Ittah M, Miceli-Richard C, Lebon P, Pallier C, Lepajolec C, Mariette X. Induction of B cell-activating factor by viral infection is a general phenomenon, but the types of viruses and mechanisms depend on cell type. Journal of Innate Immunity. 3: 200-7. PMID 21051868 DOI: 10.1159/000321194  0.68
2011 Borie R, Schneider S, Debray MP, Adle-Biasssette H, Danel C, Bergeron A, Mariette X, Aubier M, Papo T, Crestani B. Severe chronic bronchiolitis as the presenting feature of primary Sjögren's syndrome. Respiratory Medicine. 105: 130-6. PMID 21050739 DOI: 10.1016/J.Rmed.2010.07.017  0.68
2011 Nishikawa M, Owaki H, Fuji T, Soliman MM, Ashcroft DM, Watson KD, Lunt M, Symmons D, Hyrich KL, Atkinson F, Malik S, Heycock C, Saravanan V, Rynne M, Hamilton J, ... ... Mariette X, et al. Rheumatoid arthritis - treatment 180. Utility of Body Weight Classified Low-Dose Leflunomide in Japanese Rheumatoid Arthritis Rheumatology. 50. DOI: 10.1093/Rheumatology/Ker031  0.6
2010 Terrier B, Launay D, Kaplanski G, Hot A, Larroche C, Cathébras P, Combe B, de Jaureguiberry JP, Meyer O, Schaeverbeke T, Somogyi A, Tricot L, Zénone T, Ravaud P, Gottenberg JE, ... Mariette X, et al. Safety and efficacy of rituximab in nonviral cryoglobulinemia vasculitis: data from the French Autoimmunity and Rituximab registry Arthritis Care & Research. 62: 1787-1795. PMID 20740617 DOI: 10.1002/Acr.20318  0.68
2010 Mariette X, Gottenberg JE. Pathogenesis of Sjögren's syndrome and therapeutic consequences. Current Opinion in Rheumatology. 22: 471-7. PMID 20671520 DOI: 10.1097/Bor.0B013E32833C36C5  0.64
2010 Cyteval C, Miquel A, Hoa D, Daures JP, Mariette X, Combe B. Rheumatoid arthritis of the hand: monitoring with a simplified MR imaging scoring method--preliminary assessment. Radiology. 256: 863-9. PMID 20663972 DOI: 10.1148/Radiol.10091759  0.44
2010 Gilson M, Gossec L, Mariette X, Gherissi D, Guyot MH, Berthelot JM, Wendling D, Michelet C, Dellamonica P, Tubach F, Dougados M, Salmon D. Risk factors for total joint arthroplasty infection in patients receiving tumor necrosis factor α-blockers: a case-control study. Arthritis Research & Therapy. 12: R145. PMID 20637100 DOI: 10.1186/Ar3087  0.44
2010 Pham T, Claudepierre P, Constantin A, de Bandt M, Fautrel B, Gossec L, Gottenberg JE, Goupille P, Guillaume S, Hachulla E, Masson C, Morel J, Puéchal X, Saraux A, Schaeverbeke T, ... ... Mariette X, et al. Tocilizumab: therapy and safety management. Joint, Bone, Spine : Revue Du Rhumatisme. 77: S3-100. PMID 20610315 DOI: 10.1016/S1297-319X(10)70001-4  0.64
2010 Terrier B, Amoura Z, Ravaud P, Hachulla E, Jouenne R, Combe B, Bonnet C, Cacoub P, Cantagrel A, de Bandt M, Fain O, Fautrel B, Gaudin P, Godeau B, Harlé JR, ... ... Mariette X, et al. Safety and efficacy of rituximab in systemic lupus erythematosus: results from 136 patients from the French AutoImmunity and Rituximab registry. Arthritis and Rheumatism. 62: 2458-66. PMID 20506527 DOI: 10.1002/Art.27541  0.68
2010 Gottenberg JE, Ravaud P, Bardin T, Cacoub P, Cantagrel A, Combe B, Dougados M, Flipo RM, Godeau B, Guillevin L, Le Loët X, Hachulla E, Schaeverbeke T, Sibilia J, Baron G, ... Mariette X, et al. Risk factors for severe infections in patients with rheumatoid arthritis treated with rituximab in the autoimmunity and rituximab registry. Arthritis and Rheumatism. 62: 2625-32. PMID 20506353 DOI: 10.1002/Art.27555  0.64
2010 Seror R, Mariette X, Bowman S, Baron G, Gottenberg JE, Bootsma H, Boostma H, Theander E, Tzioufas A, Vitali C, Ravaud P. Accurate detection of changes in disease activity in primary Sjögren's syndrome by the European League Against Rheumatism Sjögren's Syndrome Disease Activity Index. Arthritis Care & Research. 62: 551-8. PMID 20391511 DOI: 10.1002/Acr.20173  0.76
2010 Pavy S, Toonen EJ, Miceli-Richard C, Barrera P, van Riel PL, Criswell LA, Mariette X, Coenen MJ. Tumour necrosis factor alpha -308G->A polymorphism is not associated with response to TNFalpha blockers in Caucasian patients with rheumatoid arthritis: systematic review and meta-analysis. Annals of the Rheumatic Diseases. 69: 1022-8. PMID 19966089 DOI: 10.1136/Ard.2009.117622  0.84
2010 Seror R, Ravaud P, Bowman SJ, Baron G, Tzioufas A, Theander E, Gottenberg JE, Bootsma H, Mariette X, Vitali C. EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome. Annals of the Rheumatic Diseases. 69: 1103-9. PMID 19561361 DOI: 10.1136/Ard.2009.110619  0.76
2009 Sellam J, Proulle V, Jüngel A, Ittah M, Miceli Richard C, Gottenberg JE, Toti F, Benessiano J, Gay S, Freyssinet JM, Mariette X. Increased levels of circulating microparticles in primary Sjögren's syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity. Arthritis Research & Therapy. 11: R156. PMID 19832990 DOI: 10.1186/Ar2833  0.68
2009 Pham T, Roy C, Mariette X, Lioté F, Durieux P, Ravaud P. Effect of response format for clinical vignettes on reporting quality of physician practice. Bmc Health Services Research. 9: 128. PMID 19638231 DOI: 10.1186/1472-6963-9-128  0.4
2009 Gottenberg JE, Miceli-Richard C, Ducot B, Goupille P, Combe B, Mariette X. Markers of B-lymphocyte activation are elevated in patients with early rheumatoid arthritis and correlated with disease activity in the ESPOIR cohort. Arthritis Research & Therapy. 11: R114. PMID 19627580 DOI: 10.1186/Ar2773  0.84
2009 Tubach F, Salmon D, Ravaud P, Allanore Y, Goupille P, Bréban M, Pallot-Prades B, Pouplin S, Sacchi A, Chichemanian RM, Bretagne S, Emilie D, Lemann M, Lortholary O, Lorthololary O, ... Mariette X, et al. Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective French Research Axed on Tolerance of Biotherapies registry. Arthritis and Rheumatism. 60: 1884-94. PMID 19565495 DOI: 10.1002/Art.24632  0.44
2009 Miceli-Richard C, Gestermann N, Ittah M, Comets E, Loiseau P, Puechal X, Hachulla E, Gottenberg JE, Lebon P, Becquemont L, Mariette X. The CGGGG insertion/deletion polymorphism of the IRF5 promoter is a strong risk factor for primary Sjögren's syndrome. Arthritis and Rheumatism. 60: 1991-7. PMID 19565491 DOI: 10.1002/Art.24662  0.84
2009 Pham T, Claudepierre P, Constantin A, Fautrel B, Gossec L, Gottenberg JE, Goupille P, Hachulla E, Masson C, Morel J, Saraux A, Schaeverbeke T, Wendling D, Mariette X, Sibilia J. Abatacept therapy and safety management. Joint, Bone, Spine : Revue Du Rhumatisme. 76: S3-S55. PMID 19560051 DOI: 10.1016/S1297-319X(09)74520-8  0.64
2009 Tebib J, Mariette X, Bourgeois P, Flipo RM, Gaudin P, Le Loët X, Gineste P, Guy L, Mansfield CD, Moussy A, Dubreuil P, Hermine O, Sibilia J. Masitinib in the treatment of active rheumatoid arthritis: Results of a multicentre, open-label, dose-ranging, phase 2a study Arthritis Research and Therapy. 11. PMID 19549290 DOI: 10.1186/Ar2740  0.68
2009 Miceli-Richard C, Gestermann N, Amiel C, Sellam J, Ittah M, Pavy S, Urrutia A, Girauld I, Carcelain G, Venet A, Mariette X. Effect of methotrexate and anti-TNF on Epstein-Barr virus T-cell response and viral load in patients with rheumatoid arthritis or spondylarthropathies. Arthritis Research & Therapy. 11: R77. PMID 19470150 DOI: 10.1186/Ar2708  0.84
2009 Ittah M, Miceli-Richard C, Gottenberg JE, Sellam J, Lepajolec C, Mariette X. B-cell-activating factor expressions in salivary epithelial cells after dsRNA virus infection depends on RNA-activated protein kinase activation. European Journal of Immunology. 39: 1271-9. PMID 19337998 DOI: 10.1002/Eji.200839086  0.84
2009 Duchet-Niedziolka P, Launay O, Coutsinos Z, Ajana F, Arlet P, Barrou B, Beytout J, Bouchaud O, Brouqui P, Buzyn A, Chidiac C, Couderc LJ, Debord T, Dellamonica P, Dhote R, ... ... Mariette X, et al. Vaccination in adults with auto-immune disease and/or drug related immune deficiency: results of the GEVACCIM Delphi survey. Vaccine. 27: 1523-9. PMID 19168104 DOI: 10.1016/J.Vaccine.2009.01.003  0.68
2008 Ittah M, Miceli-Richard C, Gottenberg JE, Sellam J, Eid P, Lebon P, Pallier C, Lepajolec C, Mariette X. Viruses induce high expression of BAFF by salivary gland epithelial cells through TLR- and type-I IFN-dependent and -independent pathways. European Journal of Immunology. 38: 1058-64. PMID 18350548 DOI: 10.1002/Eji.200738013  0.68
2008 Sellam J, Miceli-Richard C, Gottenberg JE, Proust A, Ittah M, Lavie F, Loiseau P, Mariette X. Is Inhibitor of differentiation 3 involved in human primary Sjögren's syndrome? Rheumatology (Oxford, England). 47: 437-41. PMID 18296721 DOI: 10.1093/Rheumatology/Ken013  0.68
2008 Lavie F, Miceli-Richard C, Ittah M, Sellam J, Gottenberg JE, Mariette X. B-cell activating factor of the tumour necrosis factor family expression in blood monocytes and T cells from patients with primary Sjögren's syndrome. Scandinavian Journal of Immunology. 67: 185-92. PMID 18201372 DOI: 10.1111/J.1365-3083.2007.02049.X  0.32
2008 Breban M, Ravaud P, Claudepierre P, Baron G, Henry YD, Hudry C, Euller-Ziegler L, Pham T, Solau-Gervais E, Chary-Valckenaere I, Marcelli C, Perdriger A, Le Loët X, Wendling D, Fautrel B, ... ... Mariette X, et al. Maintenance of infliximab treatment in ankylosing spondylitis: results of a one-year randomized controlled trial comparing systematic versus on-demand treatment. Arthritis and Rheumatism. 58: 88-97. PMID 18163509 DOI: 10.1002/Art.23167  0.4
2007 Pham T, Fautrel B, Dernis E, Goupille P, Guillemin F, Le Loët X, Ravaud P, Claudepierre P, Miceli-Richard C, de Bandt M, Breban M, Maillefert JF, Masson C, Saraux A, Schaeverbeke T, ... ... Mariette X, et al. Recommendations of the French Society for Rheumatology regarding TNFalpha antagonist therapy in patients with ankylosing spondylitis or psoriatic arthritis: 2007 update. Joint, Bone, Spine : Revue Du Rhumatisme. 74: 638-46. PMID 18065252 DOI: 10.1016/J.Jbspin.2007.10.003  0.84
2007 Miceli-Richard C, Comets E, Loiseau P, Puechal X, Hachulla E, Mariette X. Association of an IRF5 gene functional polymorphism with Sjögren's syndrome. Arthritis and Rheumatism. 56: 3989-94. PMID 18050197 DOI: 10.1002/Art.23142  0.84
2007 Terrier B, Lacroix C, Guillevin L, Hatron PY, Dhote R, Maillot F, Diot E, Sarrot-Reynauld F, Sordet C, Dubourg O, Meyer L, Mariette X, Gottenberg JE. Diagnostic and prognostic relevance of neuromuscular biopsy in primary Sjögren's syndrome-related neuropathy. Arthritis and Rheumatism. 57: 1520-9. PMID 18050172 DOI: 10.1002/Art.23102  0.68
2007 Fautrel B, Pham T, Mouterde G, Le Loët X, Goupille P, Guillemin F, Ravaud P, Cantagrel A, Dougados M, Puéchal X, Sibilia J, Soubrier M, Mariette X, Combe B, et al. Recommendations of the French Society for Rheumatology regarding TNFalpha antagonist therapy in patients with rheumatoid arthritis. Joint, Bone, Spine : Revue Du Rhumatisme. 74: 627-37. PMID 18037319 DOI: 10.1016/J.Jbspin.2007.10.001  0.6
2007 Miceli-Richard C, Dieude P, Hachulla E, Puechal X, Cornelis F, Mariette X. Tumour necrosis factor receptor 2 (TNFRSF1B) association study in Sjögren's syndrome. Annals of the Rheumatic Diseases. 66: 1684-5. PMID 17998218 DOI: 10.1136/Ard.2007.071167  0.84
2007 Miceli-Richard C, Mariette X. EBV-specific T-cell response and immunosuppression by methotrexate and TNFalpha antagonists in patients with chronic inflammatory joint disease. Joint, Bone, Spine : Revue Du Rhumatisme. 74: 560-2. PMID 17988922 DOI: 10.1016/J.Jbspin.2007.09.002  0.84
2007 Combe B, Benessiano J, Berenbaum F, Cantagrel A, Daurès JP, Dougados M, Fardellone P, Fautrel B, Flipo RM, Goupille P, Guillemin F, Le Loet X, Logeart I, Mariette X, Meyer O, et al. The ESPOIR cohort: a ten-year follow-up of early arthritis in France: methodology and baseline characteristics of the 813 included patients. Joint, Bone, Spine : Revue Du Rhumatisme. 74: 440-5. PMID 17905631 DOI: 10.1016/J.Jbspin.2007.06.001  0.6
2007 Sellam J, Costedoat-Chalumeau N, Amoura Z, Aymard G, Choquet S, Trad S, Vignes BL, Hulot JS, Berenbaum F, Lechat P, Cacoub P, Ankri A, Mariette X, Leblond V, Piette JC. Potentiation of fluindione or warfarin by dexamethasone in multiple myeloma and AL amyloidosis. Joint, Bone, Spine : Revue Du Rhumatisme. 74: 446-52. PMID 17692552 DOI: 10.1016/J.Jbspin.2006.12.006  0.68
2007 Pavy S, Dernis E, Lavie F, Maillefert JF, Mariette X, Schaeverbeke T, Cantagrel A, Claudepierre P, Flipo RM, Goupille P, Le Loet X, Saraux A, Tebib J, Wendling D, Combe B. Imaging for the diagnosis and follow-up of ankylosing spondylitis: development of recommendations for clinical practice based on published evidence and expert opinion. Joint, Bone, Spine : Revue Du Rhumatisme. 74: 338-45. PMID 17591453 DOI: 10.1016/J.Jbspin.2007.04.001  0.68
2007 Lavie F, Pavy S, Dernis E, Goupille P, Cantagrel A, Tebib J, Claudepierre P, Flipo RM, Le Loët X, Maillefert JF, Mariette X, Saraux A, Schaeverbeke T, Wendling D, Combe B. Pharmacotherapy (excluding biotherapies) for ankylosing spondylitis: development of recommendations for clinical practice based on published evidence and expert opinion. Joint, Bone, Spine : Revue Du Rhumatisme. 74: 346-52. PMID 17590370 DOI: 10.1016/J.Jbspin.2007.04.003  0.68
2007 Dernis E, Lavie F, Pavy S, Wendling D, Flipo RM, Saraux A, Cantagrel A, Claudepierrre P, Goupille P, Le Loët X, Maillefert JF, Mariette X, Schaeverbeke T, Tebib J, Combe B. Clinical and laboratory follow-up for treating and monitoring patients with ankylosing spondylitis: development of recommendations for clinical practice based on published evidence and expert opinion. Joint, Bone, Spine : Revue Du Rhumatisme. 74: 330-7. PMID 17590366 DOI: 10.1016/J.Jbspin.2007.04.002  0.68
2007 Sellam J, Hamdi H, Roy C, Baron G, Lemann M, Puéchal X, Breban M, Berenbaum F, Humbert M, Weldingh K, Salmon D, Ravaud P, Emilie D, Mariette X. Comparison of in vitro-specific blood tests with tuberculin skin test for diagnosis of latent tuberculosis before anti-TNF therapy. Annals of the Rheumatic Diseases. 66: 1610-5. PMID 17456528 DOI: 10.1136/Ard.2007.069799  0.68
2007 Terrier B, Ittah M, Tourneur L, Louache F, Soumelis V, Lavie F, Casadevall N, Candon S, Hummel A, Mariette X, Buzyn A. Late-onset neutropenia following rituximab results from a hematopoietic lineage competition due to an excessive BAFF-induced B-cell recovery. Haematologica. 92: e20-3. PMID 17405749 DOI: 10.3324/Haematol.11031  0.68
2007 Gottenberg JE, Loiseau P, Azarian M, Chen C, Cagnard N, Hachulla E, Puechal X, Sibilia J, Charron D, Mariette X, Miceli-Richard C. CTLA-4 +49A/G and CT60 gene polymorphisms in primary Sjögren syndrome Arthritis Research and Therapy. 9. PMID 17341301 DOI: 10.1186/Ar2136  0.68
2007 Sellam J, Miceli-Richard C, Gottenberg JE, Ittah M, Lavie F, Lacabaratz C, Gestermann N, Proust A, Lambotte O, Mariette X. Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjögren's syndrome and systemic lupus erythematosus. Annals of the Rheumatic Diseases. 66: 790-7. PMID 17185325 DOI: 10.1136/Ard.2006.065656  0.68
2007 Lazure T, Miceli-Richard C, Sellam J, Fabre M, Mariette X, Guettier C. Small hepatic vein involvement in IgG multiple myeloma: a very unusual pattern of liver infiltration. Virchows Archiv : An International Journal of Pathology. 450: 127-9. PMID 17111130 DOI: 10.1007/S00428-006-0297-Z  0.84
2007 Lavie F, Miceli-Richard C, Ittah M, Sellam J, Gottenberg JE, Mariette X. Increase of B cell-activating factor of the TNF family (BAFF) after rituximab treatment: insights into a new regulating system of BAFF production. Annals of the Rheumatic Diseases. 66: 700-3. PMID 17040963 DOI: 10.1136/Ard.2006.060772  0.84
2007 Seror R, Sordet C, Guillevin L, Hachulla E, Masson C, Ittah M, Candon S, Le Guern V, Aouba A, Sibilia J, Gottenberg JE, Mariette X. Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sjögren's syndrome. Annals of the Rheumatic Diseases. 66: 351-7. PMID 16950808 DOI: 10.1136/Ard.2006.057919  0.76
2007 Pham T, Fautrel B, Dernis E, Goupille P, Guillemin F, Le Loët X, Ravaud P, Claudepierre P, Miceli-Richard C, De Bandt M, Breban M, Maillefert JF, Masson C, Saraux A, Schaeverbeke T, ... ... Mariette X, et al. Recommendations of the French Society for Rheumatology Regarding TNF α; antagonist therapy in patients with ankylosing spondylitis or psoriatic arthritis: 2007 update{lozenge, open}{lozenge, open}Pour citer cet article, utiliser ce titre en anglais et sa référence dans le même volume de Joint Bone Spine. | Recommandations de la Société française de rhumatologie pour l'utilisation des agents anti-TNF dans la spondylarthrite ankylosante et le rhumatisme psoriasique : mise à jour 2007 Revue Du Rhumatisme (Edition Francaise). 74: 1312-1322. DOI: 10.1016/J.Rhum.2007.10.612  0.84
2007 Gottenberg J, Candon S, Desmoulins F, Bengoufa D, Chatenoud L, Mariette X. Dosage quantitatif des anticorps anti-SSA, anti-SSB, et anti-RNP au cours du syndrome de Sjögren primitif: corrélation à BAFF, aux biomarqueurs lymphocytaires B, et à l'activité de la maladie Revue Du Rhumatisme. 74: 1032. DOI: 10.1016/j.rhum.2007.10.583  0.4
2006 Hamdi H, Mariette X, Godot V, Weldingh K, Hamid AM, Prejean MV, Baron G, Lemann M, Puechal X, Breban M, Berenbaum F, Delchier JC, Flipo RM, Dautzenberg B, Salmon D, et al. Inhibition of anti-tuberculosis T-lymphocyte function with tumour necrosis factor antagonists. Arthritis Research & Therapy. 8: R114. PMID 16859506 DOI: 10.1186/Ar1994  0.32
2006 Pham T, Guillemin F, Claudepierre P, Luc M, Miceli-Richard C, Fautrel B, de Bandt M, Breban M, Goupille P, Maillefert JF, Masson C, Saraux A, Schaeverbeke T, Wendling D, Mariette X, et al. TNFalpha antagonist therapy in ankylosing spondylitis and psoriatic arthritis: recommendations of the French Society for Rheumatology. Joint, Bone, Spine : Revue Du Rhumatisme. 73: 547-53. PMID 16843030 DOI: 10.1016/J.Jbspin.2006.02.005  0.84
2006 Fautrel B, Constantin A, Morel J, Vittecoq O, Cantagrel A, Combe B, Dougados M, Le Loët X, Mariette X, Pham T, Puéchal X, Sibilia J, Soubrier M, Ravaud P. Recommendations of the French Society for Rheumatology. TNFalpha antagonist therapy in rheumatoid arthritis. Joint, Bone, Spine : Revue Du Rhumatisme. 73: 433-41. PMID 16798046 DOI: 10.1016/J.Jbspin.2006.04.001  0.6
2006 Champey J, Corruble E, Gottenberg JE, Buhl C, Meyer T, Caudmont C, Bergé E, Pellet J, Hardy P, Mariette X. Quality of life and psychological status in patients with primary Sjögren's syndrome and sicca symptoms without autoimmune features. Arthritis and Rheumatism. 55: 451-7. PMID 16739213 DOI: 10.1002/Art.21990  0.64
2006 Gottenberg JE, Pallier C, Ittah M, Lavie F, Miceli-Richard C, Sellam J, Nordmann P, Cagnard N, Sibilia J, Mariette X. Failure to confirm coxsackievirus infection in primary Sjögren's syndrome. Arthritis and Rheumatism. 54: 2026-8. PMID 16732567 DOI: 10.1002/Art.21906  0.68
2006 Pham T, Gossec L, Constantin A, Pavy S, Bruckert E, Cantagrel A, Combe B, Flipo RM, Goupille P, Le Loët X, Mariette X, Puéchal X, Schaeverbeke T, Sibilia J, Tebib J, et al. Cardiovascular risk and rheumatoid arthritis: clinical practice guidelines based on published evidence and expert opinion. Joint, Bone, Spine : Revue Du Rhumatisme. 73: 379-87. PMID 16690341 DOI: 10.1016/J.Jbspin.2006.01.014  0.64
2006 Gossec L, Pavy S, Pham T, Constantin A, Poiraudeau S, Combe B, Flipo RM, Goupille P, Le Loët X, Mariette X, Puéchal X, Wendling D, Schaeverbeke T, Sibilia J, Tebib J, et al. Nonpharmacological treatments in early rheumatoid arthritis: clinical practice guidelines based on published evidence and expert opinion. Joint, Bone, Spine : Revue Du Rhumatisme. 73: 396-402. PMID 16626995 DOI: 10.1016/J.Jbspin.2006.01.008  0.64
2006 Pavy S, Constantin A, Pham T, Gossec L, Maillefert JF, Cantagrel A, Combe B, Flipo RM, Goupille P, Le Loët X, Mariette X, Puéchal X, Schaeverbeke T, Sibilia J, Tebib J, et al. Methotrexate therapy for rheumatoid arthritis: clinical practice guidelines based on published evidence and expert opinion. Joint, Bone, Spine : Revue Du Rhumatisme. 73: 388-95. PMID 16626993 DOI: 10.1016/J.Jbspin.2006.01.007  0.64
2006 Ittah M, Miceli-Richard C, Eric Gottenberg J, Lavie F, Lazure T, Ba N, Sellam J, Lepajolec C, Mariette X. B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjögren's syndrome. Arthritis Research & Therapy. 8: R51. PMID 16507175 DOI: 10.1186/Ar1912  0.84
2006 Gottenberg JE, Sellam J, Ittah M, Lavie F, Proust A, Zouali H, Sordet C, Sibilia J, Kimberly RP, Mariette X, Miceli-Richard C. No evidence for an association between the -871 T/C promoter polymorphism in the B-cell-activating factor gene and primary Sjögren's syndrome. Arthritis Research & Therapy. 8: R30. PMID 16507129 DOI: 10.1186/Ar1884  0.68
2006 Gottenberg JE, Cagnard N, Lucchesi C, Letourneur F, Mistou S, Lazure T, Jacques S, Ba N, Ittah M, Lepajolec C, Labetoulle M, Ardizzone M, Sibilia J, Fournier C, Chiocchia G, ... Mariette X, et al. Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjögren's syndrome. Proceedings of the National Academy of Sciences of the United States of America. 103: 2770-5. PMID 16477017 DOI: 10.1073/Pnas.0510837103  0.68
2006 Vauloup C, Krzysiek R, Greangeot-Keros L, Wendling D, Goupille P, Brault R, Brousse C, Mariette X, Emilie D. Effects of tumor necrosis factor antagonist treatment on hepatitis C-related immunological abnormalities European Cytokine Network. 17: 290-293. DOI: 10.1684/Ecn.2006.0046  0.32
2006 Pham T, Guillemin F, Claudepierre P, Luc M, Miceli-Richard C, Fautrel B, de Bandt M, Breban M, Goupille P, Maillefert JF, Masson C, Saraux A, Schaeverbeke T, Wendling D, Mariette X, et al. TNFα antagonist therapy in ankylosing spondylitis and psoriatic arthritis: recommendations of the French Society for Rheumatology {lozenge, open}{lozenge, open}Pour citer cet article, utiliser ce titre en anglais et sa référence dans le même volume de Joint Bone Spine. | Recommandations de la Société française de rhumatologie pour l'utilisation des agents anti-TNFα dans la spondylarthrite ankylosante et le rhumatisme psoriasique Revue Du Rhumatisme (Edition Francaise). 73: 936-943. DOI: 10.1016/J.Rhum.2006.02.014  0.84
2005 Fermand JP, Katsahian S, Divine M, Leblond V, Dreyfus F, Macro M, Arnulf B, Royer B, Mariette X, Pertuiset E, Belanger C, Janvier M, Chevret S, Brouet JC, Ravaud P, et al. High-dose therapy and autologous blood stem-cell transplantation compared with conventional treatment in myeloma patients aged 55 to 65 years: long-term results of a randomized control trial from the Group Myelome-Autogreffe. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 9227-33. PMID 16275936 DOI: 10.1200/Jco.2005.03.0551  0.68
2005 Ittah M, Gottenberg JE, Proust A, Hachulla E, Puechal X, Loiseau P, Mariette X, Miceli-Richard C. No evidence for association between 1858 C/T single-nucleotide polymorphism of PTPN22 gene and primary Sjögren's syndrome. Genes and Immunity. 6: 457-8. PMID 15933742 DOI: 10.1038/sj.gene.6364229  0.68
2005 Salliot C, Lavie F, Azria A, Clerc D, Miquel A, Mariette X. Retroperitoneal fibrosis secondary to spondylodiscitis after infection with Prevotella. The Journal of Rheumatology. 32: 957-8. PMID 15868637  0.68
2005 Gottenberg JE, Lavie F, Abbed K, Gasnault J, Le Nevot E, Delfraissy JF, Taoufik Y, Mariette X. CD4 CD25high regulatory T cells are not impaired in patients with primary Sjögren's syndrome. Journal of Autoimmunity. 24: 235-42. PMID 15848046 DOI: 10.1016/J.Jaut.2005.01.015  0.68
2005 Gottenberg JE, Busson M, Cohen-Solal J, Lavie F, Abbed K, Kimberly RP, Sibilia J, Mariette X. Correlation of serum B lymphocyte stimulator and β2 microglobulin with autoantibody secretion and systemic involvement in primary Sjögren's syndrome Annals of the Rheumatic Diseases. 64: 1050-1055. PMID 15640273 DOI: 10.1136/Ard.2004.030643  0.68
2004 Lavie F, Miceli-Richard C, Quillard J, Roux S, Leclerc P, Mariette X. Expression of BAFF (BLyS) in T cells infiltrating labial salivary glands from patients with Sjögren's syndrome. The Journal of Pathology. 202: 496-502. PMID 15095277 DOI: 10.1002/Path.1533  0.84
2003 Roux S, Bergot C, Fermand JP, Frija J, Brouet JC, Mariette X. Evaluation of bone mineral density and fat-lean distribution in patients with multiple myeloma in sustained remission. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 18: 231-6. PMID 12568400 DOI: 10.1359/Jbmr.2003.18.2.231  0.68
2000 Mariette X, Brouet JC, Chevret S, Leger JM, Clavelou P, Pouget J, Vallat JM, Vial C. A randomised double blind trial versus placebo does not confirm the benefit of alpha-interferon in polyneuropathy associated with monoclonal IgM. Journal of Neurology, Neurosurgery, and Psychiatry. 69: 279-80. PMID 10960293 DOI: 10.1136/Jnnp.69.2.279  0.68
2000 de Kerviler E, Guermazi A, Zagdanski AM, Meignin V, Gossot D, Oksenhendler E, Mariette X, Brice P, Frija J. Image-guided core-needle biopsy in patients with suspected or recurrent lymphomas. Cancer. 89: 647-52. PMID 10931465 DOI: 10.1002/1097-0142(20000801)89:3<647::AID-CNCR21>3.0.CO;2-R  0.68
1999 Mariette X, Molina JM, Asli B, Brouet JC. A patient with chronic lymphoid leukemia and recurrent necrotic herpetic lymphadenitis. The American Journal of Medicine. 107: 403-4. PMID 10527048 DOI: 10.1016/S0002-9343(99)00178-3  0.68
1999 Abad S, Zagdanski AM, Brechignac S, Thioliere B, Brouet JC, Mariette X. Neurolymphomatosis in Waldenström's macroglobulinaemia. British Journal of Haematology. 106: 100-3. PMID 10444169 DOI: 10.1046/J.1365-2141.1999.01482.X  0.68
1999 Mariette X, Zagdanski AM, Guermazi A, Bergot C, Arnould A, Frija J, Brouet JC, Fermand JP. Prognostic value of vertebral lesions detected by magnetic resonance imaging in patients with stage I multiple myeloma. British Journal of Haematology. 104: 723-9. PMID 10192431 DOI: 10.1046/J.1365-2141.1999.01244.X  0.68
1999 Allez M, Mariette X, Linares G, Bertheau P, Jian R, Brouet JC. Low-grade MALT lymphoma mimicking Waldenström's macroglobulinemia. Leukemia. 13: 484-5. PMID 10086741 DOI: 10.1038/sj.leu.2401206  0.68
1998 Gossot D, de Kerviler E, Brice P, Mariette X, Meignin V, Cazals-Hatem D, Frija J, Célérier M. Surgical endoscopic techniques in the diagnosis and follow-up of patients with lymphoma. The British Journal of Surgery. 85: 1107-10. PMID 9718007 DOI: 10.1046/J.1365-2168.1998.00774.X  0.68
1998 de Kerviler E, Guermazi A, Gossot D, Cazals-Hatem D, Zagdanski AM, Mariette X, Brice P, Frija J. Use of an abdominal compression device for CT-guided biopsy of enlarged abdominal or pelvic lymph nodes. Journal of Vascular and Interventional Radiology : Jvir. 9: 353-7. PMID 9540922 DOI: 10.1016/S1051-0443(98)70280-5  0.68
1997 Mariette X, Chastang C, Clavelou P, Louboutin JP, Leger JM, Brouet JC. A randomised clinical trial comparing interferon-alpha and intravenous immunoglobulin in polyneuropathy associated with monoclonal IgM. The IgM-associated Polyneuropathy Study Group. Journal of Neurology, Neurosurgery, and Psychiatry. 63: 28-34. PMID 9221964 DOI: 10.1136/Jnnp.63.1.28  0.68
1995 Mariette X, Bergot C, Ravaud P, Roux C, Laval-Jeantet M, Brouet JC, Fermand JP. Evolution of bone densitometry in patients with myeloma treated with conventional or intensive therapy. Cancer. 76: 1559-63. PMID 8635058 DOI: 10.1002/1097-0142(19951101)76:9<1559::AID-CNCR2820760910>3.0.CO;2-R  0.4
1995 Fermand JP, Ravaud P, Chevret S, Leblond V, Divine M, Dreyfus F, Belanger C, Troussard X, Mariette X, Brouet JC. High-dose therapy and autologous blood stem cell transplantation in multiple myeloma: preliminary results of a randomized trial involving 167 patients. Stem Cells (Dayton, Ohio). 13: 156-9. PMID 8520505 DOI: 10.1002/stem.5530130725  0.68
1995 Mariette X, Cherot P, Cazals D, Brocheriou C, Brouet JC, Agbalika F. Antibodies to HTLV-I in Sjögren's syndrome. Lancet (London, England). 345: 71. PMID 7865009 DOI: 10.1016/S0140-6736(95)91200-2  0.68
1995 Mariette X, Clauvel JP, Brouet JC. Intensive therapy in AL amyloidosis and light-chain deposition disease. Annals of Internal Medicine. 123: 553. PMID 7661505 DOI: 10.7326/0003-4819-123-7-199510010-00017  0.68
1994 Brouet JC, Mariette X, Gendron MC, Dubreuil ML. Monoclonal IgM from patients with peripheral demyelinating neuropathies cross-react with bacterial polypeptides. Clinical and Experimental Immunology. 96: 466-9. PMID 8004816 DOI: 10.1111/j.1365-2249.1994.tb06052.x  0.68
1994 Cattan S, Mariette X, Labrousse F, Brouet JC. Iliac artery dissection in alpha 1-antitrypsin deficiency. Lancet (London, England). 343: 1371-2. PMID 7910366 DOI: 10.1016/S0140-6736(94)92513-5  0.68
1993 Mariette X, Levy Y, Dubreuil ML, Intrator L, Danon F, Brouet JC. Characterization of a human monoclonal autoantibody directed to cardiolipin/beta 2 glycoprotein I produced by chronic lymphocytic leukaemia B cells. Clinical and Experimental Immunology. 94: 385-90. PMID 8222331 DOI: 10.1111/J.1365-2249.1993.Tb03461.X  0.68
1993 Mariette X, Brouet JC, Danon F, Tsapis A, Lassoued K. Nucleotide sequence analysis of the VL and VH domains of five human IgM directed to lamin B. Evidence for an antigen-driven process in the generation of human autoantibodies to lamin B. Arthritis and Rheumatism. 36: 1315-24. PMID 8216425 DOI: 10.1002/Art.1780360916  0.68
1993 Mariette X, Agbalika F, Daniel MT, Bisson M, Lagrange P, Brouet JC, Morinet F. Detection of human T lymphotropic virus type I tax gene in salivary gland epithelium from two patients with Sjögren's syndrome. Arthritis and Rheumatism. 36: 1423-8. PMID 8216402 DOI: 10.1002/Art.1780361015  0.68
1993 Mariette X, Tsapis A, Oksenhendler E, Daniel MT, D'Agay MF, Berger R, Brouet JC. Nodular lymphocyte predominance Hodgkin's disease featuring blood atypical polyclonal B-cell lymphocytosis. British Journal of Haematology. 85: 813-5. PMID 7918051 DOI: 10.1111/j.1365-2141.1993.tb03231.x  0.68
1993 Mariette X, Tsapis A, Brouet JC. Nucleotidic sequence analysis of the variable domains of four human monoclonal IgM with an antibody activity to myelin-associated glycoprotein. European Journal of Immunology. 23: 846-51. PMID 7681398 DOI: 10.1002/Eji.1830230412  0.68
1992 Mariette X, Khalifa P, Ravaud P, Frija J, Laval-Jeantet M, Chastang C, Brouet JC, Fermand JP. Bone densitometry in patients with multiple myeloma. The American Journal of Medicine. 93: 595-8. PMID 1466354 DOI: 10.1016/0002-9343(92)90190-M  0.68
1992 Brouet JC, Mariette X, Chevalier A, Hauttecoeur B. Determination of the affinity of monoclonal human IgM for myelin-associated glycoprotein and sulfated glucuronic paragloboside. Journal of Neuroimmunology. 36: 209-15. PMID 1370669 DOI: 10.1016/0165-5728(92)90052-M  0.68
1992 Brouet JC, Mariette X, Tsapis A. Sensorimotor polyneuropathy and monoclonal IgM: A review of clinical and immunological features International Journal of Clinical & Laboratory Research. 22: 201-205. PMID 1281694 DOI: 10.1007/Bf02591424  0.68
1989 Mariette X, Mitjavila MT, Moulinie JP, Bussel A, Brouet JC, Vainchenker W, Fermand JP. Rifampicin-induced pure red cell aplasia The American Journal of Medicine. 87: 459-460. PMID 2508471 DOI: 10.1016/S0002-9343(89)80833-2  0.68
Show low-probability matches.